Devices, systems, and methods for closing the left atrial appendage

Information

  • Patent Grant
  • 11826050
  • Patent Number
    11,826,050
  • Date Filed
    Wednesday, April 21, 2021
    3 years ago
  • Date Issued
    Tuesday, November 28, 2023
    5 months ago
Abstract
Described here are devices, systems and methods for closing the left atrial appendage. Some of the methods described here utilize one or more guide members having alignment members to aid in positioning of a closure device. In general, these methods include advancing a first guide having a first alignment member into the left atrial appendage, advancing a second guide, having a second alignment member, into the pericardial space, aligning the first and second alignment members, advancing a left atrial appendage closure device into the pericardial space and adjacent to the left atrial appendage, and closing the left atrial appendage with the closure device. In these variations, the closure device typically has an elongate body having a proximal end and a distal end, and a closure element at least partially housed within the elongate body. The closure element comprises a loop defining a continuous aperture therethrough.
Description
FIELD

In general, the devices, systems, and methods described here are for closing off a portion of tissue, e.g., the left atrial appendage, using a surgical, minimally invasive, or intravascular approach.


BACKGROUND

Atrial fibrillation is a common problem that afflicts millions of patients. Unfortunately, atrial fibrillation often results in the formation of a thrombus, or clot, in the appendage of the left atrium. This presents a problem, inasmuch as the thrombus can dislodge and embolize to distant organs, resulting in adverse events such as a stroke. For this reason, most patients with atrial fibrillation are treated with a blood thinner to help prevent the formation of a thrombus. Blood thinners, however, can present health risks (e.g., bleeding), particularly in the elderly, and often also require that the user make significant lifestyle changes.


Several methods have been developed to address the potential problem of thrombus formation in the left atrial appendage. One such method is suturing along the base, or ostial neck of the appendage, where it joins the atrial chamber. In this way, blood flow into the atrial appendage is cut-off, eliminating the risk of thrombus formation therein. This is typically done through open-heart surgery, making the availability of the procedure available to only those who are otherwise undergoing an open-heart procedure, or who are at particularly high risk. In addition, open-heart surgery requires general anesthesia and has a number of well-know risks, making it less desirable.


Other methods have also been investigated. For example, methods of stapling the base of the appendage and methods have been investigated, as have methods of filling the appendage with a space occupying, or occluding member. However, stapling is not a preferred method given the fragility of the appendage and the likelihood of its rupture. Occlusion devices may not effectively prevent all blood flow into the appendage, leaving areas of potential thrombus formation.


Additional devices and methods for closing the left atrial appendage would therefore be desirable. In particular, devices and methods for closing the left atrial appendage using minimally invasive, intravascular, or a combination of these techniques, would be desirable in order to avoid the need for opening the chest. Of course, additional devices for use in open surgical procedures are desirable as well, especially when those devices offer additional advantages over standard devices.


BRIEF SUMMARY

Described here are devices, systems and methods for closing the left atrial appendage. Some of the methods described here utilize one or more guide members having alignment members to aid in positioning of a closure device. In general, these methods comprise advancing a first guide having a first alignment member into the left atrial appendage, advancing a second guide, having a second alignment member, into the pericardial space, aligning the first and second alignment members, advancing a left atrial appendage closure device into the pericardial space and adjacent to the left atrial appendage, and closing the left atrial appendage with the closure device. In these variations, the closure device typically comprises an elongate body having a proximal end and a distal end, and a closure element at least partially housed within the elongate body. The closure element comprises a loop defining a continuous aperture therethrough.


Any of the devices used in any of the methods described here may be advanced under any of a variety of visualization techniques, e.g., fluoroscopic visualization, ultrasound, etc. For example, the first guide, second guide, or both guides may be advanced under fluoroscopic visualization in some variations. Similarly, any of the devices used in any of the methods described here may be advanced over a guide element or guide wire. For example, the first guide, second guide, closure device, any additional guide, or any combination thereof, may be advanced over a guidewire. In some variations, the second guide is coupled to the closure device for at least a portion of the method.


The alignment members may be, or may comprise, any suitable alignment member. For example, they may be or may comprise magnets, radiopaque markers, echogenic markings, members configured to produce one or more audible signals, interconnecting or interlocking members, one or more vacuum members, or the like. In some variations, the alignment members are magnets.


The first guide may further comprise an expandable member, e.g., an expandable cage, an expandable strutted structure, an expandable balloon, or the like. In some variations, the expandable member comprises an expandable balloon. The expandable member may be used for any suitable purpose, e.g., to atraumatically displace tissue, to help with identifying, sizing, protecting, isolating, stabilizing, or positioning tissue, or the like. In some variations, the expandable member is expanded within the left atrial appendage. In other variations of the methods described here, a third guide is advanced into the left atrial appendage, where the third guide has a proximal end and a distal end and comprises an expandable member. In some additional variations, the first and third guides are coupled together for at least a portion of the method. Again, the expandable member may comprise any suitable expandable member. In some variations, the expandable member is a balloon, which may or may not have one or more apertures therein. The apertures, for example, may be useful in enabling inflation and deflation of the balloon, may be useful for enabling passage of one or more guides or guidewires therethrough, or may be useful in enabling delivery of fluids, such as saline, contrast, drugs, etc., distal of the balloon.


The closure device may further comprise a suture for encircling the left atrial appendage after it has been closed with the closure device. Of course, the closure device may also have the ability to encircle the left atrial appendage without having a suture coupled thereto. The closure element alone may capture and release the left atrial appendage (i.e., it can open and close around the left atrial appendage), which may help facilitate optimal closure of the left atrial appendage, prior to permanent exclusion. In some variations, where a suture is used, the suture may comprise a surgical slip knot. The suture may or may not be coupled to the closure element.


The methods described here may further comprise tensioning the suture. The methods may additionally comprise releasing the tension on the suture, e.g., to help facilitate repositioning of the device, and the like. The methods may further comprise releasing the suture from the closure element, tightening the suture, and severing the suture. When the methods include severing the suture, the suture, may be severed in any suitable fashion. For example, the suture may be severed with a cutting element, or may be severed by the application of energy (e.g., light energy, thermal energy, RF energy, electrical energy, magnetic energy, electromagnetic energy, kinetic energy, chemical energy and combinations thereof). When a cutting element is used, it may be an element on the closure device itself, or it may be part of a separate device.


The methods described here may also include confirming satisfactory or optimal closure of the left atrial appendage prior to permanent exclusion, excluding or opening the left atrial appendage with the closure device, repositioning the closure device, reclosing the left atrial appendage, and permanently excluding the left atrial appendage.


Other methods for closing the left atrial appendage are also described. In these methods, a closure device is advanced into the pericardial space and adjacent to the left atrial appendage, the left atrial appendage is closed with the closure device, the left atrial appendage is secured with a suture, and then the suture is severed. In these variations, the closure device typically comprises an elongate body having a proximal end and a distal end, and a closure element that comprises a loop defining a continuous aperture therethrough.


As with the methods described just above, the severing of the suture maybe accomplished in any suitable fashion. For example, the suture may be severed with a cutting element, or by the application of energy (e.g., light energy, thermal energy, RF energy, electrical energy, magnetic energy, electromagnetic energy, kinetic energy, chemical energy and combinations thereof). When a cutting element is used, it may be an element on the closure device itself, or may be part of a separate device, or some combination of both may be used.


The closure device may comprise one or more expandable elements, and the closure device, the suture, or both may comprise a radiopaque material, echogenic material, or some combination thereof. In some variations, the closure device is made from a shape-memory material (e.g., a nickel titanium alloy, or the like), and in some variations, the suture is coupled to the closure device. In these methods, the closure device may be visualized while advanced, e.g., using fluoroscopy, ultrasound, a combination thereof, etc., and may or may not be advanced over a guide element or guidewire.


Additional methods for closing a left atrial appendage are also described here. These methods typically comprise advancing a first guide having a proximal end and a distal end into the left atrial appendage, through the left atrial appendage, and out of the left atrial appendage, such that one of the proximal or distal ends is within the vasculature, and one of the proximal or distal ends is within a subthoracic space, and advancing a left atrial appendage closure device into the pericardial space and adjacent to the left atrial appendage, and closing the left atrial appendage with the closure device. In these methods, the closure device typically comprises an elongate body having a proximal end and a distal end, and a closure element housed within the elongate body, where the closure element comprises a loop defining a continuous aperture therethrough.


In these methods, the proximal end of the first guide may be within the vasculature, or within the stubthoracic space. In some variations, the closure device is advanced into the pericardial space over the first guide. Again, as with all the methods described here, any of the devices may be advanced under any of a variety of visualization techniques. For example, the first guide, closure device, or both may be advanced under fluoroscopic or ultrasound visualization, or both. In some variations, the methods further comprise advancing a second guide into the left atrial appendage, where the second guide has a proximal end, a distal end, and comprises an expandable member. The expandable member may be any suitable expandable member (e.g., expandable struts, expandable cage, expandable balloon, or the like). In some variations, the first and second guides are coupled together for at least a portion of the method.


Devices for closing the left atrial appendage are also described here. Some of the devices described here comprise an elongate body having a proximal end and a distal end, a closure element comprising a loop defining a continuous aperture therethrough at least partially housed within the elongate body, and a suture loop. The suture loop may or may not be coupled to the closure element. For example, the device may further comprise a retention member, where the retention member is configured to retain the closure element and the suture loop. The retention member may be configured to accomplish this task in any suitable fashion. For example, it may comprise first and second lumens, where the closure element is housed within the first lumen and the suture loop is housed within the second lumen. The second lumen may have a weakened region, a perforated region, or a slit or other opening configured to release and/or close the suture with the application of a force. In other variations, the retention member and the closure element are withdrawn or otherwise removed, leaving behind and/or closing the suture loop. In still other variations, the retention member comprises a first lumen and one or more releasable retention elements, where the closure element is housed within the first lumen and the suture loop is retained by the one or more releasable retention elements. The retention element may be any suitable element, for example, a releasable prong, a polymer tack, and the like.


The closure element may be made from any suitable material. In some variations, the closure element is made from a shape-memory material (e.g., a nickel titanium alloy). Similarly, the suture loop may be made from any suitable material (e.g., any suitable material useful for exclusion or closure). It may be bioabsorbable (e.g., biodegradable polymers, etc.), or non-bioabsorbable (e.g., non-biodegradable polymers, metals, etc.). The closure element, suture loop, or both may comprise a radiopaque or echogenic material.


In some variations, the elongate body has one or more curves along its length. The elongate body may or may not be steerable, and may or may not be configured as a catheter. In some variations, the closure element and the suture loop are separately actuatable. In other variations, the device further comprises a cutting element.


Systems for closing a left atrial appendage are also described here. Typically, the systems comprise a first guide having a size and length adapted for accessing the left atrial appendage through the vasculature, where the first guide comprises a first alignment member, a second guide having a size and length adapted for accessing the pericardial space from a subthoracic region, where the second guide comprises a second alignment member, and a closure device comprising an elongate body having a proximal end and a distal end, and a closure element housed at least partially therein, where the closure element comprises a loop defining a continuous aperture therethrough. The system may further comprise any suitable or useful device or component.


For example, in some variations the system further comprises an expandable member. The expandable member may be any suitable expandable member, and in some variations the expandable member is an expandable balloon with or without one or more apertures therein. The expandable member may be configured to be couplable to the first guide.


The systems described here may further comprise a suture, which may or may not be coupled to, or couplable with, the closure device. The systems may also comprise a device or element for severing the suture. In some variations, the closure device is couplable to the second guide.


The first and second alignment members may be any suitable alignment members. For example, they may be or may comprise magnets, radiopaque markers, echogenic markings, members configured to produce one or more audible signals, interconnecting or interlocking members, one or more vacuum members, or the like. In some variations, the alignment members are magnets, which may or may not be located at the distal ends of the first and second guides. The systems may further comprise instructions for using the first guide, second guide, closure device, or any combination thereof. In some variations, the elongate body of the closure device has one or more curves along its length, and the systems further comprise a straightening tube, configured to temporarily straighten the one or more curves.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 provides a cross-sectional representation of a heart showing various anatomical structures.



FIGS. 2A-2B are different views of an illustrative device that may be used with the systems and methods described herein.



FIG. 3A provides a close-up view of a distal end of an illustrative device having a retention member.



FIGS. 3B-3D depict illustrative retention members that may be used with the devices described herein.



FIG. 4 provides a close-up view of a distal end of an illustrative device, without a retention member.



FIG. 5 is a depiction of an illustrative device with the catheter body removed for purposes of description and clarity.



FIG. 6 provides another depiction of an illustrative device with the catheter body removed, here, showing more of the device.



FIG. 7 is a close-up view of an illustrative suture retention mechanism, here, shown as a suture hook.



FIG. 8 is a close-up view of a distal end of an illustrative device having a lumen therethrough.



FIG. 9 is a top side view of one variation of the proximal end of the devices described here.



FIG. 10 is a skewed end view of one variation of the proximal end of the devices described here.



FIG. 11 provides a cross-sectional view of one variation of the proximal end of the devices described here.



FIG. 12 is an illustrative suture cutter that may be used with the systems and methods described here.



FIGS. 13A and 13B are illustrative guides having alignment members.



FIGS. 14A-14D depict an illustrative method of closing the left atrial appendage.



FIGS. 15A-15D depict an alternative illustrative method of closing the left atrial appendage.



FIG. 15E depicts an illustrative device that may be used to perform the method depicted in FIGS. 15A-15D.





DETAILED DESCRIPTION

Described here are devices, systems, and methods for closing the left atrial appendage. In this regard, it may be helpful to start by briefly identifying and describing the relevant heart anatomy. Shown in FIG. 1 is a cross-sectional view of the heart (100). Shown there is left atrium (102) and left ventricle (104). In between the left atrium (102) and the left ventricle (104) is the mitral valve (also known as the bicuspid valve), which is defined by a pair of mitral valve leaflets (106). The leaflets are connected to chordae tendinae (108) that are in turn, connected to papillary muscles (110). The papillary muscles join ventricular wall (112). The left atrial appendage (114) is shown adjacent to, and is formed from, the wall of the left atrium (102).


As can be seen, the left atrial appendage (114) lies within the boundaries of the pericardium (116), and is in close proximity to the ventricular wall (112). The left atrial appendage typically has a tubular shape that approximates a cone, with a slight narrowing or neck in the plane of the orifice where it joins the left atrium (102). In patients with atrial fibrillation, the left atrial appendage (114) is the most common location for thrombosis formation, which, in time, may dislodge and cause a devastating stroke. Because stroke is the primary complication of atrial fibrillation, the left atrial appendage is frequently excluded from the left atrium in those patients undergoing procedures to treat atrial fibrillation, and is often removed or excluded at the time of other surgical procedures, such as mitral valve surgery, to reduce the risk of a future stroke. The devices and systems described here, help ensure proper closure of the left atrial appendage, at the neck or base of the left atrial appendage, along the anatomic ostial plane. In this way, exclusion of the entire left atrial appendage from systemic circulation may be facilitated.


I. Devices


The devices described here for closing the left atrial appendage generally comprise a closure element having one or more loops. The devices may be suitable for use with minimally invasive access to the left atrial appendage (e.g., through a small sub-xyphoid or other intercostal incision, through an incision in the costal cartilage, through a port, through the vasculature, etc.) or may be suitable for use with open surgical procedures. The lengths of the devices may be chosen as desirable.



FIGS. 2A and 2B provide different views of an exemplary device that may be used to close the left atrial appendage. Shown in FIG. 2A is device (200) comprising an elongate body (202) having a proximal end and a distal end, and a closure element (204). In this variation, the closure element comprises a loop that defines a continuous aperture therethrough suitable for encircle the left atrial appendage therein. The closure element is at least partially housed within the elongate body (202) and may be advanced therefrom, or retracted therein. Also shown in FIG. 2A is a lumen (214) for passage of a tools or fluids therethrough. For example, the lumen (214) may enable passage of a guide (with or without an alignment member), a guidewire, a suture cutter, fluids and/or drugs, and the like. Any number of lumens may be used for any suitable purpose. Suitable lumens will be described again with reference to FIG. 8. Also shown in FIGS. 2A and 2B is handle (206) having a linear actuation slide (208) and knob (210). Additional details of the handle will be discussed below.


In the variation shown in FIGS. 2A and 2B, the elongate body (202) comprises a curve (212) at a distal portion thereof. In instances where the elongate body (202) of the device comprises one or more curves, a straightening tube, or other straightening mandrel or mechanism may be used to temporarily straighten the elongate body during delivery (e.g., until the pericardial space is reached). After a particular location has been reached, the straightening tube or mandrel may then be withdrawn. The straightening tube may be made of any suitable material (e.g., a rigid plastic, stainless, combination thereof, etc.). Of course, it should be understood that the device need not comprise one or more curves as shown in FIGS. 2A and 2B. For example, the elongate body may be straight and flexible, and a pre-curved tube or mandrel may be employed during the methods to aid in delivery and use (e.g., while advanced to the left atrial appendage). Similarly, the elongate body may be straight and flexible, and have a pull wire attached thereto, so that when the pullwire is pulled proximally, the elongate body flexes and bends. In this variation, the elongate body may be maneuvered as appropriate. It should be understood that any of the devices described here may be configured for steerability, or may be configured for robotic use (e.g., configured for use with one or more robotic or other automated type device).



FIG. 3A provides additional detail of a suitable closure element. Shown there is a distal portion (300) of a suitable closure device having an elongate body (302) and a closure element assembly (304). In FIG. 3A, details of an elongate body extension, or tip (306) can be seen. This tip may be thermoformed or injection molded, or may be integral with the rest of the elongate body (302). In instances where a suture loop (308) is used, the tip (306) may serve to house a suture knot therein. It should be understood that when reference is made to the elongate body, it is meant to include any such tip (306) as shown in FIG. 3A. Also apparent in FIG. 3A is suture loop (308), which is shown passing through the tip (306) in a proximal direction and into a retention member (312) in a distal direction. Also shown passing through tip (306) in a proximal direction and into retention member (312) in a distal direction is closure element (310), which will form a loop to encircle the left atrial appendage. As can be seen by FIG. 3A, the retention member is configured to retain the closure element and the suture loop.



FIGS. 3B-3D depict illustrative retention members that may be used with the devices described herein. FIG. 3B shows an end view of a retention member (314) having first and second lumens (316, 318) for retaining a closure element and a suture loop therein. In this variation, the second lumen (318) has a slit or other opening (320) along its length, for allowing the suture to pass therethrough when it is ready to be deployed. Of course, it should be understood that the first and second lumens may be positioned or oriented in any suitable way with respect to each other, and similarly, the slit or other opening on the second lumen may be positioned or oriented in any suitable fashion with respect to the first lumen (e.g., it may be approximately 180°, approximately 150, approximately 120, approximately 90′, approximately 60, approximately 30, or the like, from the first lumen (316)). FIG. 3C provides an illustration of a retention member having a first lumen (322), a second lumen (324), and a slit (326). In this variation, the slit (326) is positioned closer to the first lumen (322) than the slit of FIG. 3B. The width or spacing of the slit opening may selected as desired or appropriate. Similarly, the slit need not extend or be continuous along the entire length of the retention member. In some variations, the slits may have prongs or arms along its length to help capture and retain the suture therein. In other variations, the slits may be covered at spaced apart locations therealong with a biodegradable polymer, temporarily used to tack or hold down the suture. Of course, in still other variations, the retention member does not comprise a slit, and instead comprises some other type of retention mechanism, such as the prongs or tacks described just above. In yet other variations, there are no slits or openings in the retention member and the suture loop is released upon removing or withdrawing the retention member and closing the device.



FIG. 3D provides another variation of a retention member. In this variation, the retention member has a first lumen (328), second lumen (330), and a separation region (332). The separation region may be constructed in any suitable fashion. For example, the separation region may comprise a perforated region adapted to perforate and release the suture with the application of force. Alternatively, the separation region may be a thin-walled or other type of weakened region that may be configured to break and release the suture. It should be understood that the retention member may have any suitable geometry or shape, and may be made from any suitable material. Similarly, the lumens need not be full circles or have a circular cross-sectional geometry. When these or other types of retention members are used, the suture loop may be torn out, pulled through, or otherwise released from the retention member after it has been properly positioned and tightened as desirable.


The above described components may be made of any suitable material. For example, the closure element may be made from a shape-memory material, such as a shape-memory alloy (e.g., nickel titanium alloy, etc.), may be made from stainless steel, polyester, nylon, polyethylene, polypropylene, some combination thereof, etc. Similarly, the suture loop may be made of any suitable material useful in exclusion or closure, and the term “suture loop” should be understood accordingly. For example, it may be made of a biodegradable material (e.g., polylactic acid, polyglycolic acid, polylactic-co-glycolic acid, etc.), or may be made of a non-biodegradable material (e.g., metal, steel, polyester, nylon, propylene, silk, and combinations thereof). In some variations, as will be described in more detail below with reference to the methods, the suture loop is made from a biodegradable material such that the suture loop degrades after a period of time has elapsed (e.g., for sufficient scarring to be achieved). It should be understood, the any part of the device may comprise, include, or be made from a radiopaque or echogenic material to help facilitate visualization. For example, the closure element, the suture loop, the elongate body, or any combination of these components may comprise a radiopaque or echogenic material.


The suture loop and the closure element may be configured to have any appropriate perimeter. For example, they may have a perimeter of 4.5 inches in a fully expanded state, a perimeter of about 4.3 inches, about, 3.3 inches, about 4.0 inches, about 3.5 inches, about 3.3 inches, 3.0 inches, about 2.7 inches, about 2.5 inches, about 1.5 inches, about 1.25 inches, or the like. Of course, these perimeters will vary as the closure element and suture loop are actuated and retracted.


For additional clarity, FIG. 4 provides a view of distal portion (300) of FIG. 3A, without retention member (312), thus showing the looped nature of closure element (310) and suture (308). FIG. 5 is a view of distal portion (300), without retention member (312), tip (306), and elongate body (302), thus providing additional details of this variation of the device. Shown there is of course, closure element (310) and suture (308). Suture (308) further comprises a surgical knot (e.g., a one way slipknot or other suitable knot) (500). Also shown is an anchoring feature (502), here shown as a tube, for anchoring one side of the closure element (310). The opposite side of the closure element is the active or actuation side (i.e., one side remains anchored while the other side has additional active length). Of course, when anchoring is used, it may be done in any suitable way. In other variations (not shown here), both sides of the closure element are active and actuatable (i.e., neither side is anchored). The device may also comprise a suture tube (504) for facilitating suture passage.



FIG. 6 shows additional proximal detail of a suitable closure device. In this view, the elongate body and tip have been removed, but the retention member remains. Of particular interest here is suture hook (600). Suture hook (600) captures suture loop (308) so that the closure element (310) may be advanced and retracted separately from suture loop (308) when the two are coupled together. That is, the suture hook (600) prevents the suture from tightening as the closure element is actuated, so that the device may be positioned as desirable before the suture is actuated. The suture hook (600) may also help prevent excess suture from opening and closing, and thus help prevent excess suture from getting caught on anatomical structures, instruments, etc. Also shown in FIG. 6 is a proximal length of the closure element (602). In some variations, it may be useful to have at least a portion of the proximal length of the closure element (602) coated with a lubricious coating, in order to help facilitate slidable actuation. Any suitable lubricious coating may be used (e.g., PTFE, etc.). The suture hook (600) is shown in greater detail in FIG. 7. While the suture hook shown in FIG. 7 has a rounded atraumatic tip, it need not be so. Indeed, any suitable tip may be used. The suture hook may be made of any suitable material.



FIG. 8 provides details of the distal portion of an illustrative closure device (800), here comprising at least one lumen (802) in the elongate body (804). The lumen may be used for any suitable purpose. For example, it may be used to enable passage of one or more guides or guidewires therethrough, one or more tools therethorugh, or the like. The lumen may also be used as a flush lumen, a vacuum lumen, a drug delivery lumen, or the like. The elongate body may comprise any number of lumens, and it should be understood that the lumens need not traverse the entire length of the elongate body, nor form a completely bounded aperture (i.e., the use of lumens herein is intended to capture instances where a slit or groove may be used with one or more guides, guidewires, or additional tools).



FIG. 9 is one variation of a suitable handle (900) for the devices described herein. In this variation, the handle comprises a linear actuation slide (902) for actuating the closure element, and a suture knob (904) for actuating the suture. While not shown, the suture hook, described above, or similar such feature, helps enable the separate actuation capability described here. Thus when the slide (902) is pushed distally, the closure element, which has been at least partially retained within the elongate body, will be advanced distally, and the loop size of the closure element will get bigger. Conversely, when the slide is retracted proximally, the closure element will be retracted and the loop size will get smaller. The suture loop is not affected in this process. Instead, the suture loop in this variation is controlled by the suture knob. Of course, the suture loop need not be actuated by a knob. That is, the suture may be separately actuated by an additional slide, lever, button, or the like. Similarly, the closure element need not be actuated by a slide. It may be actuated by a button, knob, lever, or the like.


Also shown in FIG. 9 is suture cutting slot (906). While not easily shown in this view, the suture runs through the handle and into the knob. The suture cutting slot enables the suture to be cut easily, as the suture traverse the slot and the slot provides a viewing window and access point for suture severing. Of course, the suture need not be severed in such a fashion. In some variations, the closure device itself comprises a cutting element for severing the suture (e.g., a blade actuated by a button or some other mechanism). FIG. 10 provides a skewed end view of the handle shown in FIG. 9 so that additional details may be seen. Specifically, shown here are suture knob lock (1000) and luer fitting (1002) at the proximal end of the handle lumen.



FIG. 11 provides a cross-sectional view of a portion of handle (1100), here showing a length of the handle including the suture knob (1102) and the slide actuator (1104) in its most retracted position. Suture knob (1102) comprises an outer knob (1106), and outer knob bearing (1108), inner knob (1110) and inner knob bearing (1112), thrust bearing (1114) and slip clutch plates (1116) that when actuated (when the knob (1102) is turned or rotated) apply a tension upon the suture loop causing it to release from the retention member. In one variation, the slip clutch plates (1116) have particular force settings and are configured to provide tactile feedback to the operator indicating closure. In other variations, the clutch plates (1116) may have a particular force limitation in order to protect against shearing or cutting of tissue by the suture during release or tightening of the suture loop. For example, in these variations, once the suture loop reaches a pre-determined force, the outer knob (1106) and outer knob bearing (1108) may disengage from inner knob (1110) and inner knob bearing (1112) by slipping or the like (e.g., similar to a gas cap when overtightened).


Also shown is a suture reel area (1118) and a suture severing slot (1120), which, as described briefly above, is used to help terminate the suture by placement of blade, scalpel, or other sharp instrument therein. As described above, in some variations, the closure device itself comprises a suture cutting device or mechanism, and this may be located at the same place as the suture severing slot (1120) or some other place. For example, the device may include a blade or other cutting mechanism that may be actuated by a blade, lever, knob, etc., whether or not located in the suture severing slot location. Lumen (1122) may be used for placement of a guide (with or without an alignment member), guidewire, one or more tools (e.g., a suture cutter, visualization devices, etc.), one or more fluids (e.g., saline, drugs, etc.), as described above.


II. Methods


Methods for closing the left atrial appendage are also described here. The left atrial appendage may be accessed in any suitable fashion, and any of the devices described here may be used. For example, the left atrial appendage may be accessed from the inside of the heart, or may be accessed from the outside of the heart. In some variations, the left atrial appendage is accessed from both the inside of the heart, and the outside of the heart. Typically, the appendage is closed off from the outside of the heart, even when accessed from the inside of the heart.


In variations when the left atrial appendage is accessed from both the inside and the outside of the heart, it may be useful to employ the use of guides having alignment members. In this way, accessing the left atrial appendage may be more easily facilitated. It may also be useful to employ the use of a positioner or stabilizer, to help position devices relative to the left atrial appendage and to stabilize the appendage while it is being closed off. The positioner or stabilizer may be any suitable stabilizer or positioner, e.g., an expandable member or the like. More details of this will be described below.


In some variations, the methods of closing the left atrial appendage comprise advancing a closure device into the pericardial space and adjacent to the left atrial appendage, closing the left atrial appendage with the closure device, securing the closed left atrial appendage with a suture, and then severing the suture. The closure device may be any suitable closure device, such as a device having an elongate body with a closure element comprising a loop defining a continuous aperture therethrough, as described above. The suture may be severed in any suitable fashion, and at any suitable location along its length (i.e., from immediately adjacent to the knot at the left atrial appendage to just proximal to, or just distal to, the skin surface). In some instances it may be desirable to sever the suture at the knot itself (e.g., in instances where it is desirable to release tension on the suture entirely).


An illustrative device (1200) for severing a suture is shown in FIG. 12. The device depicted there may be threaded over the suture and then actuated to cut the suture with a blade or similar cutting feature housed within distal portion (1202). While a device having a blade housed therein is depicted in FIG. 12, any suitable cutting device may be used, and the device may be made from or comprise any suitable materials (e.g., a radiopaque or echogenic material). In some variations, the closure device has a cutting element thereon, for cutting the suture. Of course, the suture need not be severed with a blade or other such cutting feature. The suture can be severed by the application of energy. For example, the suture may be severed with the application of light energy, thermal energy, RF energy, electrical energy, magnetic energy, electromagnetic energy, kinetic energy, chemical energy, and combinations of any of the above. Additional methods will now be described.


A. Transseptal and Pericardial Access


In some variations, the methods for closing the left atrial appendage include accessing the left atrial appendage from both the inside of the heart and the outside of the heart. In these variations, one or more guides having alignment members are often used to align the inside and outside access devices together. To access the inside of the heart, the vasculature is typically used. For example, access may be obtained via one or several of the various veins or arteries (jugular, femoral, carotid, etc.). In some variations, the heart is accessed on the inside via the common femoral vein (e.g., the left common femoral vein) using a standard Seldinger technique with a needle. An introducer wire may then be advanced through the needle, followed by an introducer sheath. The introducer wire may then be removed. In some variations, a guiding catheter sheath may be placed as an alternative to an introducer sheath or the initial sheath may be replaced with a guiding catheter sheath.


Using fluoroscopy, an angiogram performed through the sheath, a catheter placed through the sheath, a guiding catheter sheath, or any combination thereof, may be performed to observe anatomical characteristics and considerations of the access route for the purpose of transseptal access into the left atrium (e.g., tortuosity, clots, devices, such as vena cava filters, etc.). Fluoroscopy, ultrasound, intracardiac echocardiography, extracardiac echocardiography, transesophageal echocardiography, or combinations thereof, may be used to help visualize transseptal access to the left atrium, and access to the left atrium may be obtained using standard transseptal access techniques.


For access to the heart from the outside, a subthoracic access point may be used. The access point is typically identified based on patient anatomic characteristics. In some variations, the access point is right of the xyphoid process and pointed towards the patient's left shoulder, but may be at any suitable location (e.g., intercostal access via a sternotomy, thoracostomy, or thoracotomy, or in the costal cartilage itself). Once the access point has been determined, a needle (e.g., a 17G Tuohy needle) may be advanced using standard pericardiocentsesis techniques under fluoroscopic guidance. After access to the pericardium has been obtained, a guidewire may be advanced through the needle under fluoroscopic visualization within the pericardiac sac. The needle may then be removed. Access to the pericardial space has thus been obtained.


Turning now to the figures, after access from the inside and outside of the heart has been obtained using the above described devices and techniques, the devices of the current invention are ready for use. For example, first (1300) and second (1302) guides having alignment members as shown in FIGS. 13A and 13B respectively may be used to guide the procedure. The alignment member may be any suitable alignment member (e.g., interconnecting elements, one or more vacuum members, radiopaque or echogenic markers, members that are configured to produce an audible response, magnets, etc.). Here, the alignment members are magnets (1304, 1306) located at the distal ends of the guides. The magnets may be made from or comprise any suitable magnetic material, e.g., a rare earth magnet, such as neodymium-iron-boron, cobalt-samarium, or other powerful fixed magnet elements. These guides may be used for guiding additional tools and/or devices to the left atrial appendage.


The guides may have any suitable lengths and/or dimensions. For example, the guides may have a diameter of about 0.010″ to about 0.050″, about 0.020″ to about 0.030″, or the like. In some variations the first guide has a diameter of about 0.025″ and the second guide has a diameter of about 0.035″. Similarly, the length may be any suitable length. For example, from about 50 cm to about 300 cm or more, from about 100 cm to about 200 cm, from about 200 cm to about 250 cm, and the like. In some variations, the first guide has a length of about 250 cm and the second guide has a length of about 90 cm. The outer diameter of the alignment element may also be selected as desirable. For example, it may be from about 0.05″ to about 0.2″ or more. In some variations, the outer diameter of the alignment member of the first guide is about 0.106″ and the outer diameter of the alignment member of the second guide is about 0.170″. It should be understood that these dimensions are suitable for any guide, not only guides having alignment members comprising one or more magnets.


For example, turning to FIG. 14A, the first guide (1400) may be advanced into the left atrial appendage (1404), while the second guide (1402) may be advanced into the pericardial space adjacent to the left atrial appendage. Either of these guides may be advanced under any of a variety of visualization techniques, e.g., fluoroscopic visualization, ultrasound visualization, some combination thereof, etc. A balloon catheter (1406) or other expandable member may be advanced over the first guide, or in conjunction with the first guide (e.g., it may be coupled to or be part of the first guide) and into the left atrial appendage as shown in FIG. 14B. Similarly, a closure device (1408) may be advanced over the second guide, or in conjunction with the second guide (e.g., it may be coupled to or be part of the second guide), as shown in FIG. 14B.


In instances where a balloon is used as an expandable member, it may be made of any suitable material. For example, it may be made of polyisoprene, or other suitable materials. Similarly, the balloon may have any suitable dimensions. For example, it may have an outer diameter of approximately 10-40 mm, approximately 20-30 mm, or the like. Similarly, it may have any suitable length. For example, it may have a length of about 5 mm to about 50 mm, about 10 mm to about 20 mm, or the like. In some variations, the balloon has an outer diameter of approximately 20-30 mm, and a length of about 20 mm.


The expandable member (in this variation, shown as an expandable balloon) is inflated to position and stabilize the left atrial appendage, as shown in FIG. 14C. In its expanded state, the expandable member helps locate the ostial plane of the left atrial appendage. Specifically, when the expandable member is expanded, the left atrial appendage is distended and its shape is changed from roughly conical to roughly spherical, thus better defining the junction between the left atrial appendage and left atrium. In addition, the expandable member in its expanded state may be at a pressure much greater than that of the left atrium proper, resulting in a significant differential in tension between the left atrial appendage and the left atrium. The expandable member may have one or more apertures therethrough for passage of contrast to facilitate visualization.


While the expandable member is still in its expanded state, a closure element (1410) of a closure device (1408) may be placed around the left atrial appendage and closed as shown in FIG. 14D. However, in some variations, the closure element is placed around the left atrial appendage while the balloon is in its deflated or unexpanded stated, and then the balloon is expanded. A suture may then be deployed from the device, tightened around the closed appendage, released from the device, and severed, leaving the closed appendage in place. Of course, in some instances it may be desirable to confirm proper closure of the appendage prior to tightening of the suture, and then again after the suture has been tightened using fluoroscopic or other visualization techniques. If closure is not adequate or otherwise not desirable, the loop may be opened, repositioned, closed, and then confirmed once again.


Specifically, it is desirable that the left atrial appendage be closed off as close to the anatomical ostial plane as possible (i.e., the opening that separates the left atrium from the left atrial appendage). If the left atrial appendage is closed off above the plane of the orifice (toward the left atrial appendage tip or away from the anatomical ostial plane), this may result in a persistent diverticulum of the left atrial appendage, which in turn may result in an additional site or nidus for thrombus formation despite complete exclusion of the left atrial appendage from the left atrium. In some individuals, the geometry of the left atrium and left atrial appendage may be such that the neck or narrowing between them is poorly defined from the epicardial, or outer aspect. In addition, the external geometry of the left atrial appendage-left atrial junction is difficult to differentiate from an epicardial perspective. This may be compounded by the fact that the anatomy is moving vigorously when the procedures are employed while the heart is beating and the lungs remain inflated (i.e., closed chest procedures). From an inside aspect, or endocardial view, fluoroscopy and ultrasound methods provide limited information or ability to landmark the true three-dimensional characteristics of the anatomic ostial plane. Thus the use of the devices described here help facilitate proper positioning and closure of the left atrium, and may be used during beating heart procedures, thus resulting in significant advantages over known left atrial appendage closure devices.


Of course, many variations on this method are possible. For example, the guides may be used as guidewires or rails for additional devices to slide over, or the guides may be coupled to the devices described just above. Additional guides or guidewires may also be used, and confirmation steps may be used throughout as appropriate. The guides having the alignment members thereon may be used or removed during the methods as appropriate or desirable. In some variations, the closure device has one or more bends or curves along its length, and a tip straightener or straightening tube is used to temporarily straighten the bend during advancement of the device into the pericardial space. In other variations, where the device includes a straight elongate body, a pre-curved device may be used to aid in delivery after proper access has been obtained. In some variations, the suture loop is made from a biodegradable material and is configured to biodegrade after sufficient time has passed to ensure scarring or formation of new tissue that effectively seals of the appendage.


B. Transseptal or Pericardial Access


In the methods described just above, access to the left atrial appendage was obtained both from inside and outside the heart. Of course, the left atrial appendage may be closed off using the systems and devices described here without performing both access procedures as described above. For example, in some variations the methods comprise advancing a first guide having a proximal end and a distal end into the left atrial appendage, through the left atrial appendage, and out of the left atrial appendage, such that one of the proximal or distal ends is within the vasculature, and one of the proximal or distal ends is within the subthoracic space.


Once access has been obtained in this fashion, a closure device may then be advanced into the pericardial space and adjacent to the left atrial appendage, and the left atrial appendage closed off. Of course, the proximal end of the first guide may be within the vasculature, or may be within the subthoracic space. In some variations the closure element is advanced into the pericardial space over the first guide. In other variations, these methods further comprise advancing a second guide into the left atrial appendage, where the second guide comprises an expandable member. The second guide may be advanced to the left atrial appendage over the first guide, though need not be advanced in such a fashion.


Other methods of closing the left atrial appendage without performing both access procedures (i.e., transseptal and epicardial) are also described here. In general, these methods comprise accessing the inside of the left atrial appendage from the epicardial space, using a device that is configured to puncture the appendage wall. An expandable member, such as a balloon, is then advanced through the puncture and into the left atrial appendage and inflated to help position the left atrial appendage while it is being closed off.


Making reference now to the figures, FIG. 15A shows a left atrial appendage closure device (1500) being advanced adjacent to the left atrial appendage (1502) from the outside of the heart. The closure device may be advanced in any suitable fashion. For example, it may be advanced via a subthoracic approach, or via intercostal or intracostal access, via open surgical access, or the like, as described above. The closure device comprises a closure element (1504) (e.g., a loop as shown in FIG. 15A) that is advanced over the left atrial appendage (1502) and tightened to close off the appendage. The device may comprise a blade or other cutting mechanism (1506), and such mechanism may be used to puncture the left atrial appendage after it has been closed, so that access may be obtained to the inside of the appendage as shown in FIG. 15B. Once access to the inside of the appendage has been obtained, an expandable member (which may be part of the closure device or be a different device meant to cooperate with the closure device) may be expanded within the left atrial appendage for positioning and such as described above. The left atrial appendage may then be closed off again (and confirmed with the visualization techniques described above), and a suture deployed to permanently fix the left atrial appendage in its closed position. The device (1500) may then be withdrawn proximally, and the suture (1510) severed using any of the techniques described above. An illustrative device (1512) for accomplishing this method is shown in FIG. 15E. Shown there is device having a proximal end (1513) and a distal end (1515), balloon (1514), retractable blade (1520), blade actuator (1516), and inflation lumen (1518) for inflating the balloon. Of course other suitable devices may also be used to accomplish this method.


III. Systems


Also described here are systems for closing a left atrial appendage. In general, the systems may comprise a closure device useful for performing a left atrial appendage closure procedure as described above, together with one or more additional components. For example, the system may comprise a first guide having a size and length adapted for accessing the left atrial appendage through the vasculature and comprising an alignment member, a second guide having a size and a length adapted for accessing the pericardial space from a subthoracic region and comprising an alignment member, and a closure device. The alignment member may be any suitable alignment member. For example, the alignment member may comprise radiopaque or echogenic markers, members configured to produce an audible response, one or more interconnecting members, one or more vacuum members, or magnets. In some variations, the alignment members of the first and second guides comprise magnets as shown in FIGS. 13A and 13B respectively.


The closure device may be any of the closure devices described above. For example, the closure device may be one having a closure element that comprises a loop defining a continuous aperture therethrough. The system may further comprise an expandable member or a device comprising an expandable member. The expandable member may be any suitable expandable member, such as, e.g., the balloon catheters described above. The expandable member may have one or more apertures therein for allowing contrast or other fluids to pass therethrough. The system may further comprise a suture loop, and the suture loop may or may not be coupled or couplable to the closure device.


The systems may also comprise one or more devices for severing the suture. Similarly, the systems may also comprise one or more devices for temporarily straightening one or more curves along the elongate body of the closure device. Of course, the device may comprise instructions for using any, all, or a portion of, the system components (e.g., first guide, second guide, closure device, straightening tube, suture cutter, or some combination thereof).


Although the foregoing invention has, for the purposes of clarity and understanding been described in some detail by way of illustration and example, it will be apparent that certain changes and modifications may be practiced, and are intended to fall within the scope of the appended claims.

Claims
  • 1. A method for closing a left atrial appendage of a heart comprising: advancing a closure device into the pericardial space and adjacent to the left atrial appendage, wherein the closure device comprises an elongate body, a closure element comprising a loop defining a continuous aperture therethrough, a suture comprising a suture loop, and a retention member comprising first and second lumens, wherein the closure element is housed within the first lumen and the suture loop is housed within the second lumen;closing the left atrial appendage with the closure element,securing the closed left atrial appendage with the suture loop;releasing the suture loop from the retention member prior to severing the suture; andsevering the suture.
  • 2. The method of claim 1, wherein securing the left atrial appendage with the suture loop comprises tensioning the suture to tighten the suture loop.
  • 3. The method of claim 1, further comprising confirming satisfactory closure of the left atrial appendage.
  • 4. The method of claim 1, wherein one or more of the closure element and the suture loop comprises a radiopaque or echogenic material.
  • 5. The method of claim 1, further comprising advancing a first guide into the left atrial appendage and advancing a second guide into the pericardial space.
  • 6. The method of claim 5, wherein the first guide comprises a first alignment member and the second guide comprises a second alignment member.
  • 7. The method of claim 6, further comprising aligning the first and second alignment members.
  • 8. The method of claim 7, further comprising advancing an expandable member into the left atrial appendage along the first guide and expanding the expandable member within the left atrial appendage.
  • 9. The method of claim 1, wherein the suture is severed with a cutting device.
  • 10. The method of claim 1, wherein the closure device is visualized during advancement using fluoroscopy.
  • 11. A method for closing a left atrial appendage of a heart comprising: advancing a closure device adjacent to the left atrial appendage from outside the heart, wherein the closure device comprises an elongate body, a closure element comprising a loop, a suture comprising a suture loop, and a retention member releasably coupling the closure element and the suture loop, wherein the retention member comprises first and second lumens, and wherein the closure element is housed within the first lumen and the suture loop is housed within the second lumen;closing the closure element around a neck of the left atrial appendage;tightening the suture loop to release the suture loop from the retention member after closing the closure element; andsevering the suture to leave the suture loop around the left atrial appendage.
  • 12. The method of claim 11, further comprising confirming satisfactory closure of the left atrial appendage.
  • 13. The method of claim 11, wherein one or more of the closure element and the suture loop comprises a radiopaque or echogenic material.
  • 14. The method of claim 11, further comprising advancing a first guide into the left atrial appendage and advancing a second guide into a pericardial space.
  • 15. The method of claim 14, wherein the first guide comprises a first alignment member and the second guide comprises a second alignment member.
  • 16. The method of claim 15, further comprising aligning the first and second alignment members.
  • 17. The method of claim 16, further comprising advancing an expandable member into the left atrial appendage along the first guide and expanding the expandable member within the left atrial appendage.
  • 18. The method of claim 11, wherein the suture is severed with a cutting device.
  • 19. The method of claim 11, wherein the closure device is visualized during advancement using fluoroscopy.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/634,982, filed on Jun. 27, 2017, which is a continuation of U.S. patent application Ser. No. 14/625,540, filed on Feb. 18, 2015, which issued as U.S. Pat. No. 10,966,725 on Apr. 6, 2021, and which is a continuation of U.S. patent application Ser. No. 12/363,381, filed on Jan. 30, 2009, which issued as U.S. Pat. No. 8,986,325 on Mar. 24, 2015, and which is a continuation of U.S. patent application Ser. No. 12/055,213, filed on Mar. 25, 2008, which issued as U.S. Pat. No. 8,771,297 on Jul. 8, 2014, and which claims priority to U.S. Provisional Patent Application Ser. No. 60/921,002, filed on Mar. 30, 2007, each of which is incorporated herein by reference in its entirety.

US Referenced Citations (464)
Number Name Date Kind
3435905 Lazarus et al. Apr 1969 A
3496932 Prisk et al. Feb 1970 A
3677597 Stipek Jul 1972 A
3802074 Hoppe Apr 1974 A
3805791 Seuberth et al. Apr 1974 A
3828790 Curtiss et al. Aug 1974 A
3841685 Kolodziej Oct 1974 A
3999555 Person Dec 1976 A
4018229 Komiya Apr 1977 A
4030509 Heilman et al. Jun 1977 A
4078305 Akiyama Mar 1978 A
4181123 Crosby Jan 1980 A
4249536 Vega Feb 1981 A
4257278 Papadofrangakis et al. Mar 1981 A
4319562 Crosby Mar 1982 A
4428375 Ellman Jan 1984 A
4596530 McGlinn Jun 1986 A
4662377 Heilman et al. May 1987 A
4765341 Mower et al. Aug 1988 A
4776844 Ueda Oct 1988 A
4817608 Shapland et al. Apr 1989 A
4901405 Grover et al. Feb 1990 A
4944753 Burgess et al. Jul 1990 A
4991578 Cohen Feb 1991 A
4991603 Cohen et al. Feb 1991 A
4998975 Cohen et al. Mar 1991 A
5033477 Chin et al. Jul 1991 A
5108406 Lee Apr 1992 A
5163942 Rydell Nov 1992 A
5163946 Li Nov 1992 A
5176691 Pierce Jan 1993 A
5181123 Swank Jan 1993 A
5181919 Bergman et al. Jan 1993 A
5226535 Rosdhy et al. Jul 1993 A
5226908 Yoon Jul 1993 A
5242459 Buelna Sep 1993 A
5243977 Trabucco et al. Sep 1993 A
5269326 Verrier Dec 1993 A
5279539 Bohan et al. Jan 1994 A
5281238 Chin et al. Jan 1994 A
5300078 Buelna Apr 1994 A
5306234 Johnson Apr 1994 A
5312423 Rosenbluth et al. May 1994 A
5318578 Hasson Jun 1994 A
5330488 Goldrath Jul 1994 A
5336229 Noda Aug 1994 A
5336231 Adair Aug 1994 A
5336252 Cohen Aug 1994 A
5385156 Oliva Jan 1995 A
5387219 Rappe Feb 1995 A
5398944 D'Alfonso et al. Mar 1995 A
5403331 Chesterfield et al. Apr 1995 A
5405351 Kinet et al. Apr 1995 A
5417684 Jackson et al. May 1995 A
5423821 Pasque Jun 1995 A
5423830 Schneebaum et al. Jun 1995 A
5433457 Wright Jul 1995 A
5433730 Alt Jul 1995 A
5443481 Lee Aug 1995 A
5449361 Preissman Sep 1995 A
5449367 Kadry Sep 1995 A
5465731 Bell et al. Nov 1995 A
5494240 Waugh Feb 1996 A
5498228 Royalty et al. Mar 1996 A
5522819 Graves et al. Jun 1996 A
5540711 Kieturakis et al. Jul 1996 A
5545178 Kensey et al. Aug 1996 A
5571161 Starksen Nov 1996 A
5591177 Lehrer Jan 1997 A
5609597 Lehrer Mar 1997 A
5624430 Eton et al. Apr 1997 A
5624453 Ahmed Apr 1997 A
5634895 Igo et al. Jun 1997 A
5636780 Green et al. Jun 1997 A
5676162 Larson, Jr. et al. Oct 1997 A
5676651 Larson, Jr. et al. Oct 1997 A
5678547 Faupel et al. Oct 1997 A
5681278 Igo et al. Oct 1997 A
5682906 Sterman et al. Nov 1997 A
5683348 Diener Nov 1997 A
5683364 Zadini et al. Nov 1997 A
5683445 Swoyer Nov 1997 A
5693059 Yoon Dec 1997 A
5693091 Larson, Jr. et al. Dec 1997 A
5699748 Linskey, Jr. et al. Dec 1997 A
5702430 Larson, Jr. et al. Dec 1997 A
5707336 Rubin Jan 1998 A
5713897 Goble et al. Feb 1998 A
5716367 Koike et al. Feb 1998 A
5716392 Bourgeois et al. Feb 1998 A
5727569 Benetti et al. Mar 1998 A
5728151 Garrison et al. Mar 1998 A
5735877 Pagedas Apr 1998 A
5741281 Martin Apr 1998 A
5752526 Cosgrove May 1998 A
5766151 Valley et al. Jun 1998 A
5766216 Gangal et al. Jun 1998 A
5766217 Christy Jun 1998 A
5769863 Garrison Jun 1998 A
5779727 Orejola Jul 1998 A
5788715 Watson, Jr. et al. Aug 1998 A
5792151 Heck et al. Aug 1998 A
5797870 March et al. Aug 1998 A
5797929 Andreas et al. Aug 1998 A
5797946 Chin Aug 1998 A
5799661 Boyd et al. Sep 1998 A
5810845 Yoon Sep 1998 A
5814052 Nakao et al. Sep 1998 A
5823946 Chin Oct 1998 A
5827216 Igo et al. Oct 1998 A
5840059 March et al. Nov 1998 A
5855586 Habara et al. Jan 1999 A
5865791 Whayne et al. Feb 1999 A
5871531 Struble Feb 1999 A
5873876 Christy Feb 1999 A
5879375 Larson, Jr. et al. Mar 1999 A
5882299 Rastegar et al. Mar 1999 A
5893869 Barnhart et al. Apr 1999 A
5895298 Faupel et al. Apr 1999 A
5895404 Ruiz Apr 1999 A
5897487 Ouchi Apr 1999 A
5897586 Molina Apr 1999 A
5900433 Igo et al. May 1999 A
5906579 Vander Salm et al. May 1999 A
5906620 Nakao et al. May 1999 A
5908429 Yoon Jun 1999 A
5908435 Samuels Jun 1999 A
5910124 Rubin Jun 1999 A
5910129 Koblish et al. Jun 1999 A
5921994 Andreas et al. Jul 1999 A
5924424 Stevens et al. Jul 1999 A
RE36269 Wright Aug 1999 E
5941819 Chin Aug 1999 A
5957936 Yoon et al. Sep 1999 A
5961440 Schweich, Jr. et al. Oct 1999 A
5964699 Rullo et al. Oct 1999 A
5968010 Waxman et al. Oct 1999 A
5972013 Schmidt Oct 1999 A
5984866 Rullo et al. Nov 1999 A
5984917 Fleischman et al. Nov 1999 A
5991668 Leinders et al. Nov 1999 A
5997525 March et al. Dec 1999 A
6006122 Smits Dec 1999 A
6010531 Donlon et al. Jan 2000 A
6015382 Zwart et al. Jan 2000 A
6045570 Epstein et al. Apr 2000 A
6048329 Thompson et al. Apr 2000 A
6059750 Fogarty et al. May 2000 A
6067942 Fernandez May 2000 A
6068603 Suzuki May 2000 A
6071281 Burnside et al. Jun 2000 A
6081738 Hinohara et al. Jun 2000 A
6083153 Rullo et al. Jul 2000 A
6090042 Rullo et al. Jul 2000 A
6095968 Snyders Aug 2000 A
6110170 Taylor et al. Aug 2000 A
6120431 Magovern et al. Sep 2000 A
6132438 Fleischman et al. Oct 2000 A
6132439 Kontos Oct 2000 A
6148230 Kenknight Nov 2000 A
6149595 Seitz et al. Nov 2000 A
6152144 Lesh et al. Nov 2000 A
6152920 Thompson et al. Nov 2000 A
6152936 Christy et al. Nov 2000 A
6155968 Wilk Dec 2000 A
6157852 Selmon et al. Dec 2000 A
6161543 Cox et al. Dec 2000 A
6162195 Igo et al. Dec 2000 A
6167889 Benetti Jan 2001 B1
6199556 Benetti et al. Mar 2001 B1
6200303 Verrior et al. Mar 2001 B1
6206004 Schmidt et al. Mar 2001 B1
6224584 March et al. May 2001 B1
6231518 Grabek et al. May 2001 B1
6237605 Vaska et al. May 2001 B1
6241667 Vetter et al. Jun 2001 B1
6258021 Wilk Jul 2001 B1
6266550 Selmon et al. Jul 2001 B1
6280415 Johnson Aug 2001 B1
6283127 Sterman et al. Sep 2001 B1
6290674 Roue et al. Sep 2001 B1
6293906 Vanden Hoek et al. Sep 2001 B1
6296630 Altman et al. Oct 2001 B1
6311692 Vaska et al. Nov 2001 B1
6311693 Sterman et al. Nov 2001 B1
6314962 Vaska et al. Nov 2001 B1
6314963 Vaska et al. Nov 2001 B1
6319201 Wilk Nov 2001 B1
6333347 Hunter et al. Dec 2001 B1
6346074 Roth Feb 2002 B1
6379366 Fleischman et al. Apr 2002 B1
6423051 Kaplan et al. Jul 2002 B1
6474340 Vaska et al. Nov 2002 B1
6485407 Alferness et al. Nov 2002 B2
6488689 Kaplan et al. Dec 2002 B1
6494211 Boyd et al. Dec 2002 B1
6551303 Van Tassel et al. Apr 2003 B1
6561969 Frazier et al. May 2003 B2
6592552 Schmidt Jul 2003 B1
6610055 Swanson et al. Aug 2003 B1
6610072 Christy et al. Aug 2003 B1
6613062 Leckrone et al. Sep 2003 B1
6632229 Yamanouchi Oct 2003 B1
6652555 Vantassel et al. Nov 2003 B1
6656175 Francischelli et al. Dec 2003 B2
6666861 Grabek Dec 2003 B1
6692491 Phan Feb 2004 B1
6733509 Nobles et al. May 2004 B2
6736774 Benetti et al. May 2004 B2
6755338 Hahnen et al. Jun 2004 B2
6786898 Guenst Sep 2004 B2
6789509 Motsinger Sep 2004 B1
6830174 Hillstead et al. Dec 2004 B2
6830576 Fleischman et al. Dec 2004 B2
6860895 Akerfeldt et al. Mar 2005 B1
6985776 Kane et al. Jan 2006 B2
7011671 Welch Mar 2006 B2
7041111 Chu May 2006 B2
7056294 Khairkhahan et al. Jun 2006 B2
7063682 Whayne et al. Jun 2006 B1
7063693 Guenst Jun 2006 B2
7175619 Koblish et al. Feb 2007 B2
7186214 Ness Mar 2007 B2
7207988 Leckrone et al. Apr 2007 B2
7226440 Gelfand et al. Jun 2007 B2
7226458 Kaplan et al. Jun 2007 B2
7264587 Chin Sep 2007 B2
7294115 Wilk Nov 2007 B1
7297144 Fleischman et al. Nov 2007 B2
7309328 Kaplan et al. Dec 2007 B2
7318829 Kaplan et al. Jan 2008 B2
7326221 Sakamoto et al. Feb 2008 B2
7331979 Khosravi et al. Feb 2008 B2
7473260 Opolski et al. Jan 2009 B2
7507200 Okada Mar 2009 B2
7597705 Forsberg et al. Oct 2009 B2
7608091 Goldfarb et al. Oct 2009 B2
7610104 Kaplan et al. Oct 2009 B2
7618425 Yamamoto et al. Nov 2009 B2
7722641 Van Der Burg et al. May 2010 B2
7758594 Lamson et al. Jul 2010 B2
7828810 Liddicoat et al. Nov 2010 B2
7842051 Dana et al. Nov 2010 B2
7846168 Liddicoat et al. Dec 2010 B2
7905900 Palermo et al. Mar 2011 B2
7918865 Liddicoat et al. Apr 2011 B2
7967808 Fitzgerald et al. Jun 2011 B2
8070693 Ayala et al. Dec 2011 B2
8075573 Gambale et al. Dec 2011 B2
8105342 Onuki et al. Jan 2012 B2
8157818 Gartner et al. Apr 2012 B2
8226682 Maruyama et al. Jul 2012 B2
8287561 Nunez et al. Oct 2012 B2
8469983 Fung et al. Jun 2013 B2
8636767 McClain Jan 2014 B2
8647367 Kassab et al. Feb 2014 B2
8715302 Ibrahim et al. May 2014 B2
8771297 Miller et al. Jul 2014 B2
8795297 Liddicoat et al. Aug 2014 B2
8795310 Fung et al. Aug 2014 B2
8814778 Kiser et al. Aug 2014 B2
8932276 Morriss et al. Jan 2015 B1
8961543 Friedman et al. Feb 2015 B2
8986325 Miller Mar 2015 B2
9089324 McCaw et al. Jul 2015 B2
9144428 Binmoeller et al. Sep 2015 B2
9186174 Krishnan Nov 2015 B2
9198664 Fung et al. Dec 2015 B2
9198683 Friedman et al. Dec 2015 B2
9271819 Liddicoat et al. Mar 2016 B2
9339295 Fung et al. May 2016 B2
9408608 Clark, III et al. Aug 2016 B2
9456818 Torrie Oct 2016 B2
9486281 Fung et al. Nov 2016 B2
9498206 Fung et al. Nov 2016 B2
9498223 Miller et al. Nov 2016 B2
9522006 Liddicoat et al. Dec 2016 B2
9724105 Kaplan et al. Aug 2017 B2
9907954 Kassab et al. Mar 2018 B2
9936956 Fung et al. Apr 2018 B2
10045784 Friedman et al. Aug 2018 B2
10052168 Krishnan Aug 2018 B2
10130369 Fung et al. Nov 2018 B2
10251650 Clark, III et al. Apr 2019 B2
10292710 Clark, III et al. May 2019 B2
10327780 Liddicoat et al. Jun 2019 B2
10716571 Fung et al. Jul 2020 B2
10799241 Fung et al. Oct 2020 B2
10806460 Liddicoat et al. Oct 2020 B2
10959734 Fung et al. Mar 2021 B2
10966725 Miller et al. Apr 2021 B2
11020122 Miller et al. Jun 2021 B2
11026690 Fung et al. Jun 2021 B2
20020016564 Courtney et al. Feb 2002 A1
20020017306 Cox et al. Feb 2002 A1
20020022860 Borillo et al. Feb 2002 A1
20020068970 Cox et al. Jun 2002 A1
20020072753 Cohen Jun 2002 A1
20020103492 Kaplan et al. Aug 2002 A1
20020107531 Schreck et al. Aug 2002 A1
20020111637 Kaplan et al. Aug 2002 A1
20020147456 Diduch et al. Oct 2002 A1
20030014049 Koblish et al. Jan 2003 A1
20030024537 Cox et al. Feb 2003 A1
20030065271 Khoury Apr 2003 A1
20030069577 Vaska et al. Apr 2003 A1
20030083542 Alferness et al. May 2003 A1
20030083669 Gleason May 2003 A1
20030083674 Gibbens, III May 2003 A1
20030120264 Lattouf Jun 2003 A1
20030158464 Bertolero Aug 2003 A1
20030181942 Sutton et al. Sep 2003 A1
20030187460 Chin et al. Oct 2003 A1
20040030335 Zenati et al. Feb 2004 A1
20040034347 Hall et al. Feb 2004 A1
20040039389 West, Jr. et al. Feb 2004 A1
20040044361 Frazier et al. Mar 2004 A1
20040049210 Vantassel et al. Mar 2004 A1
20040059352 Burbank et al. Mar 2004 A1
20040064138 Grabek Apr 2004 A1
20040068267 Harvie et al. Apr 2004 A1
20040078069 Francischelli et al. Apr 2004 A1
20040102804 Chin May 2004 A1
20040106918 Cox et al. Jun 2004 A1
20040116943 Brandt Jun 2004 A1
20040148020 Vidlund et al. Jul 2004 A1
20040158127 Okada Aug 2004 A1
20040162579 Foerster Aug 2004 A1
20040199169 Koons et al. Oct 2004 A1
20040199236 Laske et al. Oct 2004 A1
20040225212 Okerlund et al. Nov 2004 A1
20040225300 Goldfarb et al. Nov 2004 A1
20040243176 Hahnen et al. Dec 2004 A1
20040260273 Wan Dec 2004 A1
20050033274 Pless et al. Feb 2005 A1
20050033280 Francischelli et al. Feb 2005 A1
20050033287 Sra Feb 2005 A1
20050043743 Dennis Feb 2005 A1
20050043745 Alferness et al. Feb 2005 A1
20050049598 West et al. Mar 2005 A1
20050080454 Drews et al. Apr 2005 A1
20050085843 Opolski et al. Apr 2005 A1
20050107824 Hillstead et al. May 2005 A1
20050149068 Williams et al. Jul 2005 A1
20050149069 Bertolero et al. Jul 2005 A1
20050154376 Riviere et al. Jul 2005 A1
20050154404 Liddicoat Jul 2005 A1
20050165466 Morris et al. Jul 2005 A1
20050182417 Pagano Aug 2005 A1
20050256532 Nayak et al. Nov 2005 A1
20060004323 Chang et al. Jan 2006 A1
20060004388 Whayne et al. Jan 2006 A1
20060009715 Khairkhahan et al. Jan 2006 A1
20060020162 Whayne et al. Jan 2006 A1
20060020271 Stewart Jan 2006 A1
20060020336 Liddicoat Jan 2006 A1
20060034930 Khosravi et al. Feb 2006 A1
20060095066 Chang et al. May 2006 A1
20060100545 Ayala et al. May 2006 A1
20060106278 Machold et al. May 2006 A1
20060200169 Sniffin Sep 2006 A1
20060212045 Schilling et al. Sep 2006 A1
20060247672 Vidlund et al. Nov 2006 A1
20060253128 Sekine Nov 2006 A1
20060271060 Gordon Nov 2006 A1
20070010829 Nobles et al. Jan 2007 A1
20070016228 Salas Jan 2007 A1
20070032824 Terwey Feb 2007 A1
20070038229 De La Torre et al. Feb 2007 A1
20070060951 Shannon Mar 2007 A1
20070083082 Kiser et al. Apr 2007 A1
20070083225 Kiser et al. Apr 2007 A1
20070083232 Lee Apr 2007 A1
20070088369 Shaw et al. Apr 2007 A1
20070100405 Thompson et al. May 2007 A1
20070135822 Onuki et al. Jun 2007 A1
20070149988 Michler et al. Jun 2007 A1
20070156217 Kaplan et al. Jul 2007 A1
20070156220 Kaplan et al. Jul 2007 A1
20070179345 Santilli Aug 2007 A1
20070249991 Whayne et al. Oct 2007 A1
20070260278 Wheeler et al. Nov 2007 A1
20070270637 Takemoto et al. Nov 2007 A1
20070270891 McGuckin, Jr. Nov 2007 A1
20080009843 De La Torre Jan 2008 A1
20080015406 Dlugos et al. Jan 2008 A1
20080033241 Peh et al. Feb 2008 A1
20080033457 Francischelli et al. Feb 2008 A1
20080039879 Chin et al. Feb 2008 A1
20080065156 Hauser et al. Mar 2008 A1
20080097489 Goldfarb et al. Apr 2008 A1
20080140116 Bonutti Jun 2008 A1
20080154260 Hoof Jun 2008 A1
20080177179 Stubbs et al. Jul 2008 A1
20080228265 Spence et al. Sep 2008 A1
20080245371 Gruber Oct 2008 A1
20080269782 Stefanchik et al. Oct 2008 A1
20080294174 Bardsley et al. Nov 2008 A1
20080294175 Bardsley et al. Nov 2008 A1
20080312664 Bardsley et al. Dec 2008 A1
20090043317 Cavanaugh et al. Feb 2009 A1
20090088728 Dollar et al. Apr 2009 A1
20090088778 Miyamoto et al. Apr 2009 A1
20090105753 Greenhalgh et al. Apr 2009 A1
20090124847 Doty et al. May 2009 A1
20090131749 Ahmed et al. May 2009 A1
20090182326 Zenati et al. Jul 2009 A1
20090196696 Otsuka et al. Aug 2009 A1
20090312776 Kaiser et al. Dec 2009 A1
20100069925 Friedman et al. Mar 2010 A1
20100094314 Hernlund et al. Apr 2010 A1
20100174296 Vakharia et al. Jul 2010 A1
20100191253 Oostman, Jr. et al. Jul 2010 A1
20100204716 Stewart et al. Aug 2010 A1
20100331820 Prisco et al. Dec 2010 A1
20110034804 Hubregtse et al. Feb 2011 A1
20110060350 Powers et al. Mar 2011 A1
20110087270 Penner et al. Apr 2011 A1
20110092997 Kang Apr 2011 A1
20110112537 Bernstein et al. May 2011 A1
20110112569 Friedman et al. May 2011 A1
20110245850 Van Der Burg et al. Oct 2011 A1
20110295060 Zenati et al. Dec 2011 A1
20120190927 Uihlein Jul 2012 A1
20120209300 Torrie Aug 2012 A1
20140018831 Kassab et al. Jan 2014 A1
20140171733 Sternik Jun 2014 A1
20140222138 Machold et al. Aug 2014 A1
20140276911 Smith et al. Sep 2014 A1
20140330074 Morriss et al. Nov 2014 A1
20140336572 Heisel et al. Nov 2014 A1
20140336676 Pong et al. Nov 2014 A1
20140364901 Kiser et al. Dec 2014 A1
20140364907 White et al. Dec 2014 A1
20150025312 De Canniere Jan 2015 A1
20150119884 Fung et al. Apr 2015 A1
20150173765 Miller et al. Jun 2015 A1
20150182225 Morejohn et al. Jul 2015 A1
20150190135 Ibrahim et al. Jul 2015 A1
20150223813 Williamson, IV et al. Aug 2015 A1
20150250482 Slaughter et al. Sep 2015 A1
20150272618 Fung et al. Oct 2015 A1
20150313633 Gross et al. Nov 2015 A1
20150374380 Miller et al. Dec 2015 A1
20160008001 Winkler et al. Jan 2016 A1
20160106421 Eliachar et al. Apr 2016 A1
20160249932 Rogers et al. Sep 2016 A1
20160310144 Kimura et al. Oct 2016 A1
20160317155 Kimura et al. Nov 2016 A1
20160346028 Rogers et al. Dec 2016 A1
20170100183 Iaizzo et al. Apr 2017 A1
20170245866 Kiser et al. Aug 2017 A1
20170325819 Kaplan et al. Nov 2017 A1
20180000485 Ad Jan 2018 A1
20180036514 Kassab et al. Feb 2018 A1
20180085130 Fung et al. Mar 2018 A1
20180092637 Foerster Apr 2018 A1
20180193635 Kassab et al. Jul 2018 A1
20180303488 Hill Oct 2018 A1
20180325523 Friedman et al. Nov 2018 A1
20190290285 Liddicoat et al. Sep 2019 A1
20190298376 Clark, III et al. Oct 2019 A1
20190298382 Fung et al. Oct 2019 A1
20210015483 Fung et al. Jan 2021 A1
Foreign Referenced Citations (72)
Number Date Country
101242785 Aug 2008 CN
1822794 May 2010 CN
101262823 Dec 2011 CN
105263425 Jul 2018 CN
3714492 Nov 1987 DE
0625336 Nov 1994 EP
0629381 Dec 1994 EP
0705566 Apr 1996 EP
0598219 Dec 1997 EP
1010397 Jun 2000 EP
1506142 Apr 1978 GB
H06319742 Nov 1994 JP
H07296645 Nov 1995 JP
H07299073 Nov 1995 JP
H11507262 Jun 1999 JP
2001120560 May 2001 JP
2002512071 Apr 2002 JP
2002540834 Dec 2002 JP
2002540901 Dec 2002 JP
2003225241 Aug 2003 JP
2004000601 Jan 2004 JP
2005110860 Apr 2005 JP
2005296645 Oct 2005 JP
2005531360 Oct 2005 JP
2007504886 Mar 2007 JP
2010523171 Jul 2010 JP
2010527697 Aug 2010 JP
2012522596 Sep 2012 JP
6336560 Jun 2018 JP
2088162 Aug 1997 RU
WO-9401045 Jan 1994 WO
WO-9404079 Mar 1994 WO
WO-9408514 Apr 1994 WO
WO-9420029 Sep 1994 WO
WO-9533408 Dec 1995 WO
WO-9604854 Feb 1996 WO
WO-9640356 Dec 1996 WO
WO-9711644 Apr 1997 WO
WO-9743957 Nov 1997 WO
WO-9953845 Oct 1999 WO
WO-9953987 Oct 1999 WO
WO-0059383 Oct 2000 WO
WO-0061202 Oct 2000 WO
WO-03022133 Mar 2003 WO
WO-03059174 Jul 2003 WO
WO-03070133 Aug 2003 WO
WO-2004002327 Jan 2004 WO
WO-2004066828 Aug 2004 WO
WO-2005034767 Apr 2005 WO
WO-2005034802 Apr 2005 WO
WO-2005084127 Sep 2005 WO
WO-2006096805 Sep 2006 WO
WO-2006110734 Oct 2006 WO
WO-2006115689 Nov 2006 WO
WO-2007001936 Jan 2007 WO
WO-2007037516 Apr 2007 WO
WO-2007056502 May 2007 WO
WO-2008017080 Feb 2008 WO
WO-2008036408 Mar 2008 WO
WO-2008091612 Jul 2008 WO
WO-2008121278 Oct 2008 WO
WO-2008147678 Dec 2008 WO
WO-2009039191 Mar 2009 WO
WO-2009094237 Jul 2009 WO
WO-2010006061 Jan 2010 WO
WO-2010048141 Apr 2010 WO
WO-2010115030 Oct 2010 WO
WO-2012170652 Dec 2012 WO
WO-2014164028 Oct 2014 WO
WO-2016005902 Jan 2016 WO
WO-2017109923 Jun 2017 WO
WO-2019191316 Oct 2019 WO
Non-Patent Literature Citations (316)
Entry
Afibfacts.com (Date Unknown). “Cox-Maze III: The Gold Standard Treatment for Atrial Fibrillation: Developing a Surgical Option for Atrial Fibrillation,” located at http://www.afibfacts.com/Treatment_Options_for_Atrial_Fibrillation/Cox-Maze_III%_3a_The_Gold_Standard_Treatment_for_Atrial_Fibrillation , last visited on Apr. 20, 2007, 4 pages.
Albers, G.W. (Jul. 11, 1994). “Atrial Fibrillation and Stroke: Three New Studies, Three Remaining Questions,” Arch Intern Med 154:1443-1448.
Alonso, M. et al. (Mar. 4, 2003). “Complications With Femoral Access in Cardiac Catheterization. Impact of Previous Systematic Femoral Angiography and Hemostasis With VasoSeal-Es Collagen Plug,” Rev. Esp. Cardiol. 56(6):569-577.
Al-Saady, N.M et al. (1999). “Left Atrial Appendage: Structure, Function, and Role in Thromboembolism,” Heart 82:547-554.
Aronow, W.S. et al. (Apr. 2009). “Atrial Fibrillation: The New Epidemic of the Age-ing World,” Journal of Atrial Fibrillation 1(6):337-361.
Babaliaros, V.C. et al. (Jun. 3, 2008). “Emerging Applications for Transseptal Left Heart Catheterization: Old Techniques for New Procedures,” Journal of the American College of Cardiology 51(22):2116-2122.
Bath, P.M.W. et al. (2005). “Current Status of Stroke Prevention in Patients with Atrial Fibrillation,” European Heart Journal Supplements 7(Supplement C):C12-C18.
Benjamin, B.A. et al. (1994). “Effect of Bilateral Atrial Appendectomy on Postprandial Sodium Excretion in Conscious Monkeys,” Society for Experimental Biology and Medicine 2006: 1 page.
Beygui, F. et al. (2005, e-pub. Oct. 21, 2005). “Multimodality Imaging of Percutaneous Closure of the Left Atrial Appendage,” Clinical Vignette, 1 page.
Bisleri, G. et al. (Jun. 3, 2005). “Innovative Monolateral Approach for Closed-Chest Atrial Fibrillation Surgery,” The Annals of Thoracic Surgery 80:e22-e25.
Bjrk, V.O. et al. (Aug. 1961). “Sequelae of Left Ventricular Puncture with Angiocardiography,” Circulation 24:204-212.
Blackshear, J.L. et al. (Feb. 1996). “Appendage Obliteration to Reduce Stroke in Cardiac Surgical Patients With Atrial Fibrillation,” Ann. Thorac. Surg. 61(2), 13 pages.
Blackshear, J.L. et al. (Oct. 1, 2003). “Thorascopic Extracardiac Obliteration of the Left Atrial Appendage for Stroke Risk Reduction in Atrial Fibrillation,” J. Am. Coll. Cardiol. 42(7):1249-1252.
Bonanomi, G. et al. (Jan. 1, 2003). “Left Atrial Appendectomy and Maze,” Journal of the American College of Cardiology 41(1):169-171.
Bonow, R.O. et al. (1998). “Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease),” Journal of the American Heart Association 98:1949-1984.
Botham, R.J. et al. (May 1959). “Pericardial Tamponade Following Percutaneous Left Ventricular Puncture,” Circulation 19:741-744.
Brock, R. et al. (1956). “Percutaneous Left Ventricular Puncture in the Assessment of Aortic Stenosis,” Thorax 11:163-171.
Burke, R.P. et al. (1992). “Improved Surgical Approach to Left Atrial Appendage Aneurysm,” Journal of Cardiac Surgery 7(2):104-107.
Canaccord Adams (Aug. 11, 2008). “A-Fib: Near A Tipping Point,” 167 pages.
Chung, M.K. (Jul. 2003). “Current Clinical Issues in Atrial Fibrillation,” Cleveland Clinic Journal of Medicine 70(Supp. 3):S6-S11.
Coffin, L.H. (Jun. 1985). “Use of the Surgical Stapler to Obliterate the Left Atrial Appendage,” Surgery, Gynecology & Obstetric 160:565-566.
Connolly, S.J. (Sep. 7, 1999). “Preventing Stroke in Atrial Fibrillation: Why Are So Many Eligible Patients Not Receiving Anticoagulant Therapy?” Canadian Medical Association 161(5):533-534.
Corrected Notice of Allowability dated Feb. 8, 2019, for U.S. Appl. No. 15/442,216, filed Feb. 24, 2017, 5 pages.
Costa, R. et al. (2006). “Bi-Atrial Subxiphoid Epicardial Pacemaker in Superior Vena Cava Syndrome,” Arq. Bras. Cardiol. 87:e45-e47.
Cox, J.L. et al. (2004). “The Role of Surgical Intervention in the Management of Atrial Fibrillation,” Texas Heart Institute Journal 31(3):257-265.
Cox, J.L. et al. (Apr. 1991). “The Surgical Treatment of Atrial Fibrillation: IV. Surgical Technique,” J. Thorac. Cardiovasc. Surg. 101(4):584-592.
Cox, J.L. et al. (Aug. 1995). “Modification of the Maze Procedure for Atrial Flutter and Atrial Fibrillation I. Rationale and Surgical Results,” J. Thorac. Cardiovasc. Surg. 110(2):473-484.
Cox, J.L. et al. (Aug. 1995). “Modification of the Maze Procedure for Atrial Flutter and Atrial Fibrillation II. Surgical Technique of the Maze III Procedure,” J. Thorac. Cardiovasc. Surg. 110(2):485-495.
Cox, J.L. et al. (Nov. 1999). “Impact of the Maze Procedure on the Stroke Rate in Patients with Atrial Fibrillation,” J. Thorac. Cardiovasc. Surg. 118:833-840.
Crystal, E. et al. (Jan. 2003). “Left Atrial Appendage Occlusion Study (LAAOS): A Randomized Clinical Trial of Left Atrial Appendage Occlusion During Routine Coronary Artery Bypass Graft Surgery for Long-term Stroke Prevention,” Am Heart J 145(1):174-178.
D'Avila, A. et al. (Apr. 2003). “Pericardial Anatomy for the Interventional Electrophysiologist,” Journal of Cardiovascular Electrophysiology 14(4):422-430.
D'Avila, A. et al. (Nov. 2007). “Experimental Efficacy of Pericardial Instillation of Anti-inflammatory Agents During Percutaneous Epicardial Catheter Ablation to Prevent Postprocedure Pericarditis,” Journal of Cardiovascular Electrophysiology 18(11):1178-1183.
Demaria, A.N. et al. (Dec. 17, 2003). “Highlights of the Year JACC 2003,” Journal of the American College of Cardiology 42(12):2156-2166.
Deneu, S. et al. (Jul. 11, 1999). “Catheter Entrapment by Atrial Suture During Minimally Invasive Port-access Cardiac Surgery,” Canadian Journal of Anesthesia 46(10):983-986.
Deponti, R. et al. (Mar. 7, 2006). “Trans-Septal Catheterization in the Electrophysiology Laboratory: Data From a Multicenter Survey Spanning 12 Years,” Journal of the American College of Cardiology 47(5):1037-1042.
Donal, E. et al. (Sep. 2005). “The Left Atrial Appendage, a Small, Blind-Ended Structure: A Review of Its Echocardiographic Evaluation and Its Clinical Role,” Chest 128(3):1853-1862.
Donnino, R. et al. (2007). “Left Atrial Appendage Thrombus Outside of a ‘Successful’ Ligation,” European Journal of Echocardiography pp. 1-2.
Dullum, M.K.C. et al. (1999). “Xyphoid MIDCAB: Report of the Technique and Experience with a Less Invasive MIDCAB Procedure,” Heart Surgery Forum 2(1):77-81.
Extended European Search Report dated May 11, 2020 for EP Application No. 17854032.4, 9 pages.
Extended European Search Report dated Aug. 21, 2018, for EP Application No. 18168824.3 , 5 pages.
Extended European Search Report dated Dec. 13, 2019, for EP Application No. 19179162.3, 8 pages.
Extended European Search Report dated Dec. 21, 2018, for EP Application No. 18171310.8, 8 pages.
Extended European Search Report dated Feb. 10, 2017, for EP Application No. 10 759 425.1, filed on Apr. 1, 2010, 7 pages.
Extended European Search Report dated Feb. 20, 2019, for EP Application No. 18211384.5, 8 pages.
Extended European Search Report dated Jul. 10, 2015, for European Patent Application No. 15153029.2, filed on Mar. 25, 2008, 6 pages.
Extended European Search Report dated Jun. 9, 2015, for EP Application No. 12 797 543.1, filed on Jun. 7, 2012, 6 pages.
Extended European Search Report dated Mar. 15, 2018, for EP Application No. 17 166 951.8, filed on Sep. 17, 2008, 14 pages.
Extended European Search Report dated Nov. 15, 2018, for EP Application No. 16769732.5 , 7 pages.
Extended European Search Report dated Nov. 20, 2018, for EP Application No. 16769738.2 , 7 pages.
Extended European Search Report dated Oct. 14, 2016, for EP Application No. 14 779 388.9 filed on Mar. 3, 2014, 7 pages.
Extended European Search Report dated Sep. 2, 2019, for EP Application No. 17757372.2, 9 pages.
Feinberg, W.M et al. (Mar. 13, 1995). “Prevalence, Age Distribution, and Gender of Patients With Atrial Fibrillation,” Arch Intern Med 155:469-473.
Fieguth, H.G. et al. (1997). “Inhibition of Atrial Fibrillation by Pulmonary Vein Isolation and Auricular ResectionExperimental Study in A Sheep Model,” European Journal of Cardio-Thoracic Surgery 11:714-721.
Final Office Action dated Feb. 20, 2020, for U.S. Appl. No. 15/356,521, filed Nov. 18, 2016, 9 pages.
Final Office Action dated Jan. 6, 2020, for U.S. Appl. No. 15/713,376, filed Sep. 22, 2017, 8 pages.
Final Office Action dated Nov. 18, 2015, for U.S. Appl. No. 13/490,919, filed Jun. 7, 2012, 10 pages.
Final Office Action dated Apr. 1, 2016, for U.S. Appl. No. 13/033,532, filed Feb. 23, 2011, 8 pages.
Final Office Action dated Apr. 14, 2010, for U.S. Appl. No. 11/600,671, filed Nov. 15, 2006, 7 pages.
Final Office Action dated Apr. 26, 2011, for U.S. Appl. No. 12/037,802, filed Feb. 26, 2008, 9 pages.
Final Office Action dated Aug. 12, 2014, for U.S. Appl. No. 13/033,532, filed Feb. 23, 2011, 6 pages.
Final Office Action dated Aug. 30, 2018, for U.S. Appl. No. 15/203,652, filed Jul. 6, 2016, 8 pages.
Final Office Action dated Jan. 13, 2014, for U.S. Appl. No. 12/752,873, filed Apr. 1, 2010, 10 pages.
Final Office Action dated Jul. 11, 2012, for U.S. Appl. No. 13/033,532, filed Feb. 23, 2011, 8 pages.
Final Office Action dated Jul. 21, 2010, for U.S. Appl. No. 11/400,714, filed Apr. 7, 2006, 10 pages.
Final Office Action dated Jul. 24, 2012, for U.S. Appl. No. 12/212,511, filed Sep. 17, 2008, 6 pages.
Final Office Action dated Jun. 22, 2009, for U.S. Appl. No. 10/963,371, filed Oct. 11, 2004, 11 pages.
Final Office Action dated Jun. 8, 2017, for U.S. Appl. No. 14/625,540, filed Feb. 18, 2015, 14 pages.
Final Office Action dated Mar. 16, 2021 for U.S. Appl. No. 15/713,376 , filed on Sep. 22, 2017, 9 pages.
Final Office Action dated Mar. 17, 2016, for U.S. Appl. No. 12/363,359, filed Jan. 30, 2009, 9 pages.
Final Office Action dated May 16, 2012, for U.S. Appl. No. 12/363,381, filed Jan. 30, 2009, 8 pages.
Final Office Action dated May 4, 2012, for U.S. Appl. No. 12/363,359, filed Jan. 30, 2009, 10 pages.
Final Office Action dated Nov. 14, 2014, for U.S. Appl. No. 12/363,359, filed Jan. 30, 2009, 10 pages.
Final Office Action dated Nov. 23, 2018, for U.S. Appl. No. 14/928,836, filed Oct. 30, 2015, 10 pages.
Final Office Action dated Nov. 8, 2013, for U.S. Appl. No. 12/037,802, filed Feb. 26, 2008, 12 pages.
Final Office Action dated Oct. 10, 2018, for U.S. Appl. No. 15/041,777, filed Feb. 11, 2016, 13 pages.
Final Office Action dated Oct. 10, 2019, for U.S. Appl. No. 15/634,962, filed Jun. 27, 2017, 12 pages.
Final Office Action dated Oct. 18, 2012, for U.S. Appl. No. 12/124,023, filed May 20, 2008, 15 pages.
Final Office Action dated Oct. 28, 2011, for U.S. Appl. No. 12/055,213, filed Mar. 25, 2008, 15 pages.
Final Office Action dated Sep. 12, 2019, for U.S. Appl. No. 14/625,540, filed Feb. 18, 2015, 16 pages.
Final Office Action dated Sep. 17, 2019, for U.S. Appl. No. 14/928,836, filed Oct. 30, 2015, 11 pages.
Final Office Action dated Sep. 20, 2011, for U.S. Appl. No. 12/212,511, filed Sep. 17, 2008, 8 pages.
Final Office Action dated Sep. 26, 2019, for U.S. Appl. No. 15/634,982, filed Jun. 27, 2017, 7 pages.
Final Office Action dated Sep. 6, 2018, for U.S. Appl. No. 14/625,540, filed Feb. 18, 2015, 15 pages.
Fisher, D.C. et al. (Dec. 1998). “Large Gradient Across a Partially Ligated Left Atrial Appendage,” Journal of the American Society of Echocardiography 11(12):1163-1165.
Friberg, L. et al. (2006). “Stroke Prophylaxis in Atrial Fibrillation: Who Gets it and Who Does Not?” European Heart Journal 27:1954-1964.
Friedman, P.A. et al. (Aug. 2009). “Percutaneous Epicardial Left Atrial Appendage Closure: Preliminary Results of an Electrogram Guided Approach,” Journal of Cardiovascular Electrophysiology 20(8):908-915.
Fuster, V. et al. (Oct. 2001). “ACC/AHA/ESC Guidelines for the Management of Patients with Atrial Fibrillation,” European Heart Journal 22(20):1852-1923.
Garcia-Fernandez, M.A. et al. (Oct. 1, 2003). “Role of Left Atrial Appendage Obliteration in Stroke Reduction in Patients With Mitral Valve Prosthesis,” Journal of the American College of Cardiology 42(7):1253-1258.
Gardiner, G.A. Jr. et al. (Apr. 1986). “Complications of Transluminal Angioplasty,” Radiology 159:201-208.
Gillinov, A.M. (2007). “Advances in Surgical Treatment of Atrial Fibrillation,” Stroke 38(part 2):618-623.
Gilman, R.A. et al. (Apr. 1963). “Direct Left Ventricular Puncture,” California Medicine 98(4):200-203.
Goodwin, W.E. et al. (Nov. 1950). “Translumbar Aortic Puncture and Retrograde Catheterization of the Aorta In Aortography and Renal Arteriography,” Annals of Surgery 132(5):944-958.
Gottlieb, L.K. et al. (Sep. 12, 1994). “Anticoagulation in Atrial Fibrillation,” Arch Intern Med. 154:1945-1953.
Graffigna, A. et al. (1993). “Surgical Treatment of Wolff-Parkinson-White Syndrome: Epicardial Approach Without the Use of Cardiopulmonary Bypass,” J. Card. Surg. 8:108-116.
Haissaguerre, M. et al. (Nov. 2005). “Catheter Ablation of Long-Lasting Persistent Atrial Fibrillation: Clinical Outcome and Mechanisms of Subsequent Arrhythmias,” Journal of Cardiovascular Electrophysiology 16(11):1138-1147.
Halperin, J.L. et al. (Aug. 1988). “Atrial Fibrillation and Stroke: New Ideas, Persisting Dilemmas,” Journal of the American Heart Association 19(8):937-941.
Halperin, J.L. et al. (Oct. 1, 2003). “Obliteration of the Left Atrial Appendage for Prevention of Thromboembolism,” Journal of the American College of Cardiology 42(7):1259-1261.
Hammill, S.C. (May 2006). “Epicardial Ablation: Reducing the Risks,” J. Cardiovasc. Electrophysiol. 17:550-552.
Hara, H. et al. (Jan. 2008). “Percutaneous Left Atrial Appendage Obliteration,” JACC: Cardiovascular Imagin 1(1):92-93.
Hart, R.G. et al. (2001). “Atrial Fibrillation and Stroke: Concepts and Controversies,” Stroke 32:803-808.
Hart, R.G. et al. (Nov. 2, 1999). “Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention,” Annals of Internal Medicine 131(9):688-695.
Hart, R.G. (Sep. 11, 2003). “Atrial Fibrillation and Stroke Prevention,” The New England Journal of Medicine 349(11):1015-1016.
Healey, J.S. et al. (Aug. 2005). “Left Atrial Appendage Occlusion Study (LAAOS): Results of a Randomized Controlled Pilot Study of Left Atrial Appendage Occlusion During Coronary Bypass Surgery in Patients At Risk for Stroke,” American Heart Journal 150(2):288-293.
Healey, J.S. et al. (Oct. 2003). “Surgical Closure of the Left Atrial Appendage for the Prevention of Stroke: A Randomized Pilot Trial of Safety and Efficacy (The Left Atrial Appendage Occlusion Study—LAAOS),” presented at the Canadian Cardiovascular Congress 2003, Toronto, Canada, Abstract No. 666, 2 pages.
Hein, R. et al. (2005). “Patent Foramen Ovale and Left Atrial Appendage: New Devices and Methods for Closure,” Pediatric Cardiology 26(3):234-240.
Heist, E.K. et al. (Nov. 2006). “Analysis of the Left Atrial Appendage by Magnetic Resonance Angiography in Patients with Atrial Fibrillation,” Heart Rhythm 3(11):1313-1318.
Ho, I. et al. (Apr. 24, 2007). “Percutaneous Epicardial Mapping Ablation of a Posteroseptal Accessory Pathway,” Circulation 115:e418-e421.
Ho, S.Y. et al. (Nov. 1999). “Anatomy of the Left Atrium: Implications for Radiofrequency Ablation of Atrial Fibrillation,” Journal of Cardiovascular Electrophysiology 10(11):1525-1533.
Hoit, B.D. et al. (Jan. 1993). “Altered Left Atrial Compliance After Atrial Appendectomy. Influence on Left Atrial and Ventricular Filling,” Circulation Research 72(1):167-175.
Inoue, Y. et al. (Jul.-Aug. 1997). “Video Assisted Thoracoscopic and Cardioscopic Radiofrequency Maze Ablation,” Asaio Journal 43(4):334-337, Abstract Only.
International Preliminary Report on Patentability dated Mar. 26, 2019, for PCT Application No. PCT/US2017/053069, filed on Sep. 22, 2017, 5 pages.
International Preliminary Report on Patentability dated Oct. 6, 2009, for PCT Application No. PCT/US2008/003938, filed on Mar. 25, 2008, 11 pages.
International Search Report and Written Opinion dated Aug. 19, 2019, for PCT Application No. PCT/US2019/024413, filed on Mar. 27, 2019, 19 pages.
International Search Report dated Aug. 8, 2014, for PCT Application No. PCT/US2014/020030, filed on Mar. 3, 2014, 4 pages.
International Search Report dated Dec. 4, 2017, for PCT Application No. PCT/US2017/053069, filed on Sep. 22, 2017, 2 pages.
International Search Report dated Feb. 27, 2009, for PCT Application No. PCT/US2008/003938, filed on Mar. 25, 2008, 6 pages.
International Search Report dated Jul. 30, 2010, for PCT Application No. PCT/US2008/076703, filed on Sep. 17, 2008, 2 pages.
International Search Report dated Jun. 1, 2010, for PCT Application No. PCT/US2010/029668, filed on Apr. 1, 2010, 2 pages.
International Search Report dated Jun. 24, 2016, for PCT Application No. PCT/US2016/024117, filed on Mar. 24, 2016, 2 pages.
International Search Report dated May 19, 2008, for PCT Application No. PCT/US06/013459, filed on Apr. 7, 2006, 1 page.
International Search Report dated May 4, 2017, for PCT Application No. PCT/US2017/019495, filed on Feb. 24, 2017, 2 pages.
International Search Report dated Sep. 14, 2012, for PCT Patent Application No. PCT/US2012/41285, filed on Jun. 7, 2012, 2 pages.
Jas, P. et al. (2003). “Radiofrequency Ablation for Atrial Fibrillation,” European Society of Cardiology 5(Supplement H):H34-H39.
Johnson, W.D. et al. (2000). “The Left Atrial Appendage: Our Most Lethal Human Attachment! Surgical Implications,” Euro. J. Cardiothoracic. Surg. 17:718-722.
Jongbloed, M.R.M. et al. (2005). “Clinical Applications of Intracardiac Echocardiography in Interventional Procedures,” Heart 91:981-990.
Kamohara, K. et al. (Aug. 2006). “Evaluation of a Novel Device for Left Atrial Appendage Exclusion: The Second-generation Atrial Exclusion Device,” The Journal of Thoracic and Cardiovascular Surgery 132(2):340-346.
Kanderian, A.S. et al. (2008). “Success of Surgical Left Atrial Appendage Closure: Assessment by Transesophageal Echocardiography,” Journal of the American College of Cardiology 52(11):924-929.
Kato, H. et al. (Aug. 1, 1996). “Evaluation of Left Atrial Appendage Stasis in Patients With Atrial Fibrillation Using Transesophageal Echocardiography With an Intravenous Albumin-Contrast Agent,” The American Journal of Cardiology 78:365-369.
Katz, E.S. et al. (Aug. 2000). “Surgical Left Atrial Appendage Ligation is Frequently Incomplete: A Transesophageal Echocardiographic Study,” Journal of the American College of Cardiology 36(2):468-471.
Kenner, H.M. et al. (Dec. 1966). “Intrapericardial, Intrapleural, and Intracardiac Pressures During Acute Heart Failure in Dogs Studied without Thoracotomy,” Circulation Research 19:1071-1079.
Kerut, E.K. et al. (Jul. 2008). “Anatomy of the Left Atrial Appendage,” Echocardiography 25(6):669-673.
Khargi, K. et al. (2005). “Surgical Treatment of Atrial Fibrillation: A Systematic Review,” European Journal of Cardiothoracic Surgery 27:258-265.
Kim, K.B. et al. (Jan. 1998). “Effect of the Cox Maze Procedure on the Secretion of Atrial Natriuretic Peptide,” J. Thorac. Cardiovasc. Surg. 115(1):139-146; discussion 146-147.
Kistler, P.M. et al. (May 2007). “The Left Atrial Appendage: Not Just an Innocent Bystander,” J. Cardiovasc Electrophysiol 18(5):465-466.
Klein, H. et al. (Apr. 1990). “The Implantable Automatic Cardioverter-Defibrillator,” Herz 15(2):111-125, Abstract Only.
Kolb, C. et al. (Feb. 2004). “Incidence of Antitachycardia Therapy Suspension Due to Magnet Reversion in Implantable Cardioverter Defibrillators,” Pace 27:221-223.
Krikorian, J.G. et al. (Nov. 1978). “Pericardiocentesis,” Am. J. Med. 65(5):808-814.
Krum, D. et al. (2004). “Visualization of Remnants of the left Atrial Appendage Following Epicardial Surgical Removal,” Heart Rhythm 1:249.
Lacomis, J.M. et al. (2007, e-pub. Oct. 17, 2007). “Dynamic Multidimensional Imaging of the Human Left Atrial Appendage,” Europace 9:1134-1140.
Lacomis, J.M. et al. (Oct. 2003). “Multi-Detector Row CT of the Left Atrium and Pulmonary Veins before Radio-frequency Catheter Ablation for Atrial Fibrillation,” Radio Graphics 23:S35-S48.
Lee, R. et al. (1999). “The Closed Heart MAZE: A Nonbypass Surgical Technique,” The Annals of Thoracic Surgery 67:1696-1702.
Levinson, M.L. et al. (1998). “Minimally Invasive Atrial Septal Defect Closure Using the Subxyphoid Approach,” Heart Surg. Forum 1(1):49-53, Abstract Only.
Lewis, D.R. et al. (1999). “Vascular Surgical Intervention for Complications of Cardiovascular Radiology: 13 Years' Experience in a Single Centre,” Ann. R. Coll. Surg. Engl. 81:23-26.
Li, H. (2007). “Magnet Decoration, Beautiful But Potentially Dangerous For Patients with Implantable Pacemakers or Defibrillators,” Heart Rhythm 4(1):5-6.
Lindsay, B.D. (1996). “Obliteration of the Left Atrial Appendage: A Concept Worth Testing,” The Annals of Thoracic Surgery 61:515.
Lip, G.Y.H. et al. (Jun. 2001). “Thromboprophylaxis for Atrial Flutter,” European Heart Journal 22(12):984-987.
Lustgarten, D.L. et al. (May/Jun. 1999). “Cryothermal Ablation: Mechanism of Tissue Injury and Current Experience in the Treatment of Tachyarrhythmias,” Progress in Cardiovascular Diseases 41(6):481-498.
Macris, M. et al. (Jan. 1999). “Minimally Invasive Access of the Normal Pericardium: Initial Clinical Experience with a Novel Device,” Clin. Cardiol. 22(Suppl. I):I-36-I-39.
Maisch, B. et al. (Jan. 1999). “Intrapreicardial Treatment of Inflammatory and Neoplastic Pericarditis Guided by Pericardioscopy and Epicardial Biopsy-Results from a Pilot Study,” Clin. Cardiol. 22(Supp. I):I-17-I-22.
Mannam, A.P. et al. (Apr. 1, 2002). “Safety of Subxyphoid Pericardial Access Using a Blunt-Tip Needle,” The American Journal of Cardiology 89:891-893.
Mattox, K.L. et al. (May 1997). “Newer Diagnostic Measure and Emergency Management,” Ches Surg Clin N Am. 7(2):213-226, Abstract Only.
McCarthy, P.M. et al. (2008). “Epicardial Atrial Fibrillation Ablation,” Chapter 23 in Contemporary Cardiology: Atrial Fibrillation, From Bench to Bedside, Natale, A et al. eds., Humana Press,: Totowa, NJ, pp. 323-332.
McCaughan, J.J. Jr., et al. (Nov. 1957). “Aortography Utilizing Percutaneous Left Ventricular Puncture,” located at http://www.archsurg.com, last visited on Apr. 7, 2009, 73:746-751, Abstract Only.
McClelland, R.R. (1978). “Congenital Aneurysmal Dilatation of the Left Auricle Demonstrated by Sequential Cardiac Blood-Pool Scintiscanning,” J. Nucl. Med. 19(5):507-509.
Melo, J. et al. (Apr. 21, 2008). “Surgery for Atrial Fibrillation in Patients with Mitral Valve Disease: Results at Five Years from the International Registry of Atrial Fibrillation Surgery,” The Journal of Thoracic and Cardiovascular Surgery 135(4):863-869.
Miller, P.S.J. et al. (Feb. 2005). “Are Cost Benefits of Anticoagulation for Stroke Prevention in Atrial Fibrillation Underestimated?” Stroke 36:360-366.
Miyasaka, Y. et al. (Jul. 11, 2006). “Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence,” Circulation 114:119-125.
Morris, J.J. Jr. (1979). “Transvenous versus Transthoracic Cardiac Pacing,” Chapter 16 in Cardiac Pacing: A Concise Guide to Clinical Practice, pp. 239-245.
Mrz, T. et al. (Apr. 2007). “Role of Echocardiography in Percutaneous Occlusion of the left Atrial Appendage,” Echocardiography 24(4):401-404.
Naclerio, E.A. et al. (1979). “Surgical Techniques for Permanent Ventricular Pacing,” Chapter 10 in Cardiac Pacing: A Concise Guide to Clinical Practice, pp. 145-168.
Nakai, T. et al. (May 7, 2002). “Percutaneous Left Atrial Appendage Occlusion (PLAATO) for Preventing Cardioembolism: First Experience in Canine Model,” Circulation 105:2217-2222.
Nakajima, H. et al. (2004). “Consequence of Atrial Fibrillation and the Risk of Embolism After Percutaneous Mitral Commissurotomy: The Necessity of the Maze Procedure,” The Annals of Thoracic Surgery 78:800-806.
Non-Final Office Action dated Mar. 20, 2020 for U.S. Appl. No. 14/625,540, filed Feb. 18, 2015, 15 pages.
Non-Final Office Action dated Mar. 29, 2013, for U.S. Appl. No. 12/752,873, filed Apr. 1, 2010, 15 pages.
Non-Final Office Action dated Mar. 31, 2015, for U.S. Appl. No. 13/490,919, filed Jun. 7, 2012, 14 pages.
Non-Final Office Action dated May 14, 2020 for U.S. Appl. No. 16/149,911, filed Oct. 2, 2018, 8 pages.
Non-Final Office Action dated Oct. 16, 2017, for U.S. Appl. No. 15/080,410, filed Mar. 24, 2016, 14 pages.
Non-Final Office Action dated Sep. 18, 2013, for U.S. Appl. No. 12/055,213, filed Mar. 25, 2008, 15 pages.
Non-Final Office Action dated Apr. 2, 2012, for U.S. Appl. No. 12/212,511, filed Sep. 17, 2008, 5 pages.
Non-Final Office Action dated Apr. 2, 2014, for U.S. Appl. No. 13/033,532, filed Feb. 23, 2011, 8 pages.
Non-Final Office Action dated Apr. 27, 2021 for U.S. Appl. No. 16/269,435, filed Feb. 6, 2019 9 pages.
Non-Final Office Action dated Apr. 28, 2011, for U.S. Appl. No. 12/055,213, filed Mar. 25, 2008, 20 pages.
Non-Final Office Action dated Aug. 18, 2020 for U.S. Appl. No. 15/713,376, filed Sep. 22, 2017, 8 pages.
Non-Final Office Action dated Aug. 6, 2008 for U.S. Appl. No. 10/963,371, filed Oct. 11, 2004, 11 pages.
Non-Final Office Action dated Dec. 2, 2016, for U.S. Appl. No. 14/625,540, filed Feb. 18, 2015, 19 pages.
Non-Final Office Action dated Dec. 22, 2011, for U.S. Appl. No. 13/033,532, filed Feb. 23, 2011, 8 pages.
Non-Final Office Action dated Dec. 30, 2009, for U.S. Appl. No. 11/400,714, filed Apr. 7, 2006, 8 pages.
Non-Final Office Action dated Feb. 17, 2011, for U.S. Appl. No. 12/212,511, filed Sep. 17, 2008, 14 pages.
Non-Final Office Action dated Jan. 12, 2018, for U.S. Appl. No. 14/928,836, filed Oct. 30, 2015, 11 pages.
Non-Final Office Action dated Jan. 16, 2013, for U.S. Appl. No. 12/037,802, filed Feb. 26, 2008, 10 pages.
Non-Final Office Action dated Jan. 17, 2018, for U.S. Appl. No. 15/041,777, filed Feb. 11, 2016, 12 pages.
Non-Final Office Action dated Jan. 26, 2018, for U.S. Appl. No. 14/625,540, filed Feb. 18, 2015, 15 pages.
Non-Final Office Action dated Jul. 22, 2010, for U.S. Appl. No. 12/037,802, filed Feb. 26, 2008, 10 pages.
Non-Final Office Action dated Jul. 29, 2020 for U.S. Appl. No. 15/634,982, filed Jun. 27, 2017, 9 pages.
Non-Final Office Action dated Jun. 17, 2014, for U.S. Appl. No. 12/363,359, filed Jan. 30, 2009, 7 pages.
Non-Final Office Action dated Jun. 26, 2009, for U.S. Appl. No. 11/600,671, filed Nov. 15, 2006, 9 pages.
Non-Final Office Action dated Jun. 27, 2019, for U.S. Appl. No. 15/356,521, filed Nov. 18, 2016, 18 pages.
Non-Final Office Action dated Mar. 13, 2008 for U.S. Appl. No. 10/963,371, filed Oct. 11, 2004, 14 pages.
Non-Final Office Action dated Mar. 15, 2019, for U.S. Appl. No. 15/634,982, filed Jun. 27, 2017, 10 pages.
Non-Final Office Action dated Mar. 25, 2021 for U.S. Appl. No. 16/375,660, filed Apr. 4, 2019, 13 pages.
Non-Final Office Action dated Mar. 27, 2019, for U.S. Appl. No. 14/625,540, filed Feb. 18, 2015, 14 pages.
Non-Final Office Action dated Mar. 7, 2012, for U.S. Appl. No. 12/124,023, filed May 20, 2008, 13 pages.
Non-Final Office Action dated May 23, 2019, for U.S. Appl. No. 15/713,376, filed Sep. 22, 2017, 7 pages.
Non-Final Office Action dated May 30, 2019, for U.S. Appl. No. 14/928,836, filed Oct. 30, 2015, 10 pages.
Non-Final Office Action dated May 31, 2013, for U.S. Appl. No. 12/124,023, filed May 20, 2008, 13 pages.
Non-Final Office Action dated May 4, 2015, for U.S. Appl. No. 12/124,023, filed May 20, 2008, 8 pages.
Non-Final Office Action dated Nov. 10, 2014, for U.S. Appl. No. 12/752,873, filed Apr. 1, 2010, 10 pages.
Non-Final Office Action dated Nov. 15, 2010, for U.S. Appl. No. 12/055,213, filed Mar. 25, 2008, 18 pages.
Non-Final Office Action dated Nov. 9, 2011, for U.S. Appl. No. 12/363,381, filed Jan. 30, 2009, 10 pages.
Non-Final Office Action dated Oct. 27, 2011, for U.S. Appl. No. 12/363,359, filed Jan. 30, 2009, 11 pages.
Non-Final Office Action dated Oct. 28, 2015, for U.S. Appl. No. 13/033,532, filed Feb. 23, 2011, 9 pages.
Non-Final Office Action dated Sep. 10, 2015, for U.S. Appl. No. 12/363,359, filed Jan. 30, 2009, 12 pages.
Notice of Allowance dated Apr. 11, 2016, for U.S. Appl. No. 14/195,797, filed Mar. 3, 2014, 13 pages.
Notice of Allowance dated Dec. 3, 2020 for U.S. Appl. No. 14/625,540, filed Feb. 18, 2015, 10 pages.
Notice of Allowance dated Dec. 9, 2020 for U.S. Appl. No. 16/149,911, filed Oct. 2, 2018, 7 pages.
Notice of Allowance dated Feb. 5, 2019, for U.S. Appl. No. 15/041,777, filed Feb. 11, 2016, 12 pages.
Notice of Allowance dated Feb. 9, 2021 for U.S. Appl. No. 15/356,521, filed Nov. 18, 2016, 8 pages.
Notice of Allowance dated Jan. 22, 2021 for U.S. Appl. No. 15/634,982, filed Jun. 27, 2017, 5 pages.
Notice of Allowance dated Jan. 30, 2020 for U.S. Appl. No. 15/634,962, filed Jun. 27, 2017, 9 pages.
Notice of Allowance dated Jan. 9, 2019, for U.S. Appl. No. 15/442,216, filed Feb. 24, 2017, 9 pages.
Notice of Allowance dated Jul. 13, 2018, for U.S. Appl. No. 15/080,398, filed Mar. 24, 2016, 8 pages.
Notice of Allowance dated Jul. 13, 2020 for U.S. Appl. No. 14/928,836, filed Oct. 30, 2015, 3 pages.
Notice of Allowance dated Jul. 19, 2016, for U.S. Appl. No. 13/490,919, filed Jun. 7, 2012, 10 pages.
Notice of Allowance dated Mar. 12, 2020 for U.S. Appl. No. 15/934,144, filed Mar. 23, 2018, 9 pages.
Notice of Allowance dated May 28, 2020 for U.S. Appl. No. 14/928,836, filed Oct. 30, 2015, 8 pages.
Notice of Allowance dated Nov. 20, 2018, for U.S. Appl. No. 15/203,652, filed Jul. 6, 2016, 8 pages.
Notice of Allowance dated Apr. 1, 2014, for U.S. Appl. No. 12/363,381, filed Jan. 30, 2009, 9 pages.
Notice of Allowance dated Apr. 3, 2014, for U.S. Appl. No. 12/037,802, filed Feb. 26, 2008, 8 pages.
Notice of Allowance dated Dec. 29, 2014, for U.S. Appl. No. 12/363,381, filed Jan. 30, 2009, 9 pages.
Notice of Allowance dated Feb. 22, 2013, for U.S. Appl. No. 12/212,511, filed Sep. 17, 2008, 8 pages.
Notice of Allowance dated Jul. 22, 2015, for U.S. Appl. No. 12/752,873, filed Apr. 1, 2010, 8 pages.
Notice of Allowance dated Mar. 18, 2013, for U.S. Appl. No. 12/212,511, filed Sep. 17, 2008, 6 pages.
Notice of Allowance dated Mar. 4, 2014, for U.S. Appl. No. 12/055,213, filed Mar. 25, 2008, 9 pages.
Notice of Allowance dated Nov. 24, 2010, for U.S. Appl. No. 11/400,714, filed Apr. 7, 2006, 8 pages.
Notice of Allowance dated Oct. 21, 2015, for U.S. Appl. No. 12/124,023, filed May 20, 2008, 9 pages.
Notice of Allowance dated Sep. 17, 2010, for U.S. Appl. No. 10/963,371, filed Oct. 11, 2004, 7 pages.
Notice of Allowance dated Sep. 17, 2010, for U.S. Appl. No. 11/600,671, filed Nov. 15, 2006, 7 pages.
Notice of Allowance dated Sep. 18, 2020 for U.S. Appl. No. 14/928,836, filed Oct. 30, 2015, 3 pages.
Odell, J.A. et al. (1996). “Thorascopic Obliteration of the Left Atrial Appendage: Potential for Stroke Reduction?” Ann. Thorac. Surg. 61:565-569.
O'Donnell, M. et al. (2005). “Emerging Therapies for Stroke Prevention in Atrial Fibrillation,” European Heart Journal 7(Supplement C):C19-C27.
Omran, H. et al. (1997). “Left Atrial Appendage Function in Patients with Atrial Flutter,” Heart 78:250-254.
Onalan, O. et al. (2005). “Nonpharmacologic Stroke Prevention in Atrial Fibrillation,” Expert Rev. Cardiovasc. Ther. 3(4):619-633.
Onalan, O. et al. (2007). “Left Atrial Appendage Exclusion for Stroke Prevention in Patients With Nonrheumatic Atrial Fibrillation,” Stroke 38(part 2):624-630.
Ostermayer, S. et al. (2003). “Percutaneous Closure of the Left Atrial Appendage,” Journal of Interventional Cardiology 16(6):553-556.
Ota, T. et al. (2006). “Epicardial Atrial Ablation Using a Novel Articulated Robotic Medical Probe Via a Percutaneous Subxiphoid Approach,” National Institute of Health 1(6):335-340.
Ota, T. et al. (Oct. 2007). “Impact of Beating Heart left Atrial Ablation on Left-sided Heart Mechanics,” The Journal of Thoracic and Cardiovascular Surgery 134:982-988.
Partial European Search Report dated Dec. 8, 2017, for EP Application No. 17 166 951.8, filed on Sep. 17, 2008, 15 pages.
Pennec, P-Y. et al. (2003). “Assessment of Different Procedures for Surgical Left Atrial Appendage Exclusion,” The Annals of Thoracic Surgery 76:2167-2168.
Perk, G. et al. (Aug. 2009). “Use of Real Time Three-Dimensional Transesophageal Echocardiography in Intracardiac Catheter Based Interventions,” J. Am Soc Echocardiogr 22(8):865-882.
Pollick C. (Feb. 2000). “Left Atrial Appendage Myopathy,” Chest 117(2):297-308.
Poulsen, T.S. et al. (Feb. 15, 2005). “Is Aspirin Resistance or Female Gender Associated With a High Incidence of Myonecrosis After Nonurgent Percutaneous Coronary Intervention?” J. Am. Coll. Cardiol. 45(4):635-636.
Reznik, G. et al. (Oct. 1992). “Percutaneous Endoscopic Implantation of Automatic Implantable Cardioverter/Defibrillator (AICD): An Animal Study of a New Nonthoracotomy Technique,” J. Laparoendosc. Surg. 2(5):255-261, Abstract Only.
Robicsek, F. (1987). “Closed-Chest Decannulation of Transthoracically Inserted Aortic Balloon Catheter without Grafting,” Journal of Cardiac Surgery 2(2):327-329.
Ross, J. Jr. et al. (Jun. 3, 2008). “Transseptal Left Heart Catheterization: A 50-Year Odyssey,” Journal of the American College of Cardiology 51(22):2107-2115.
Rubin, D.N. et al. (Oct. 1, 1996). “Evaluation of Left Atrial Appendage Anatomy and Function in Recent-Onset Atrial Fibrillation by Transesophageal Echocardiography,” Am J Cardiol 78:774-778.
Ruchat, P. et al. (2002). “Off-pump Epicardial Compartmentalization for Ablation of Atrial Fibrillation,” Interactive Cardio Vascular and Thoracic Surgery 1:55-57.
Salzberg, S.P. et al. (2008). “Surgical Left Atrial Appendage Occlusion: Evaluation of a Novel Device with Magnetic Resonance Imaging,” European Journal of Cardiothoracic Surgery 34:766-770.
Sapp, J. et al. (Dec. 2001). “Electrophysiology and Anatomic Characterization of an Epicardial Accessory Pathway,” Journal of Cardiovascular Electrophysiology 12(12):1411-1414.
Scharf, C. et al. (2005). “Catheter Ablation for Atrial Fibrillation: Pathophysiology, Techniques, Results and Current Indications,” Continuous Medical Education 8:53-61.
Scherr, D. et al. (Apr. 2009). “Incidence and Predictors of left Atrial Thrombus Prior to Catheter Ablation of Atrial Fibrillation,” Journal of Cardiovascular Electrophysiology 20(4):379-384.
Schmidt, H. et al. (Sep. 2001). “Prevalence of Left Atrial Chamber and Appendage Thrombi in Patients With Atrial Flutter and Its Clinical Significance,” Journal of the American College of Cardiology 38(3):778-784.
Schneider, B. et al. (2005, e-pub. Aug. 22, 2005). “Surgical Closure of the Left Atrial Appendage—A Beneficial Procedure?” Cardiology 104:127-132.
Schweikert, R.A. et al. (2005). “Epicardial Access: Present and Future Applications for Interventional Electrophysiologists,” Chapter 25 in New Arrhythmia Technolgies, Wang, P.J. ed., Blackwell Publishing, pp. 242-256.
Schweikert, R.A. et al. (Sep. 16, 2003). “Percutaneous Pericardial Instrumentation for Endo-Epicardial Mapping of Previously Failed Ablation,” Circulation 108:1329-1335.
Seferovic, P. et al. (Jan. 1999). “Initial Clinical Experience with the PerDUCER Device: Promising New Tool in the Diagnosis and Treatment of Pericardial Disease,” Clin. Cardiol. 22(Supp I):I-30-I-35.
Sengupta, P.P. et al. (2005). “Transoesophageal Echocardiography,” Heart 91:541-547.
Sharada, K. et al. (2005). “Non-Surgical Transpericardial Catheter Ablation of Post-Infarction Ventricular Tachycardia,” Indian Heart J 57:58-61.
Sievert, H. et al. (Apr. 23, 2002). “Percutaneous Left Atrial Appendage Transcatheter Occlusion to Prevent Stroke in High-Risk Patients With Atrial Fibrillation,” Circulation 105:1887-1889.
Singer, D.E. et al. (Sep. 2004). “Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy,” Chest 126(3):429S-456S.
Smith, P.W. et al. (Nov. 1956). “Diagnosis of Mitral Regurgitation by Cardioangiography,” Circulation 14:847-853.
Soejima, K. et al. (2004). “Subxiphoid Surgical Approach for Epicardial Catheter-Based Mapping and Ablation in Patients With Prior Cardiac Surgery or Difficult Pericardial Access,” Circulation 110:1197-1201.
Sosa, E. et al. (1996). “A New Technique to Perform Epicardial Mapping in the EP Laboratory,” J. Cardiovasc. Electrophysiol. 7(6):531-536.
Sosa, E. et al. (Apr. 2005). “Epicardial Mapping and Ablation Techniques to Control Centricular Tachycardia,” Journal of Cardiovasc. Electrphsiol. 16(4):449-452.
Sosa, E. et al. (Dec. 14, 1999). “Different Ways of Approaching the Normal Pericardial Space,” Circulation 100(24):e115-e116.
Sosa, E. et al. (Jul. 15, 2002). “Gaining Access to the Pericardial Space,” The American Journal of Cardiology 90:203-204.
Sosa, E. et al. (Mar. 1998). “Endocardial and Epicardial Ablation Guided by Nonsurgical Transthoracic Epicardial Mapping to Treat Recurrent Ventricular Tachycardia,” J. Cardiovasc. Elecytophysiol. 9(3):229-239.
Sparks, P.B. et al. (2001). “Is Atrial Flutter a Risk Factor for Stroke?” Journal of the American College of Cardiology 38(3):785-788.
Spodick, D.H. (Nov. 1970). “Medical History of the Pericardium,” The American Journal of Cardiology 26:447-454.
Stewart, J.M. et al. (Apr. 1992). “Bilateral Atrial Appendectomy Abolishes Increased Plasma Atrial Natriuretic Peptide Release and Blunts Sodium and Water Excretion During Volume Loading in Conscious Dogs,” Circulation Research 70(4):724-732.
Stewart, S. (1974). “Placement of the Sutureless Epicardial Pacemaker Lead by the Subxiphoid Approach,” Ann. Of Thoracic Surg. 18(3):308-313.
Stllberger, C. et al. (2000). “Is the Left Atrial Appendage Our Most Lethal Attachment?” European Journal of Cardio-Thoracic Surgery 18:625-626.
Stllberger, C. et al. (2006). “Stroke Prevention by Means of Epicardial Occlusion of the Left Atrial Appendage,” Journal of Thoracic and Cardiovascular Surgery 132(1):207-208.
Stllberger, C. et al. (2007). “Arguments Against Left Atrial Appendage Occlusion for Stroke Prevention,” Stroke 38:e77.
Stllberger, C. et al. (2007). “Leave the Left Atrial Appendage Untouched for Stroke Prevention!” Journal of Thoracic and Cardiovascular Surgery 134(2):549-550.
Stllberger, C. et al. (Dec. 2003). “Elimination of the Left Atrial Appendage To Prevent Stroke or Embolism ?: Anatomic, Physiologic, and Pathophysiologic Considerations,” 124(6):2356-2362.
Stoddard, M.F. et al. (1995). “Left Atrial Appendage Thrombus is not Uncommon in Patients with Acute Atrial Fibrillation and a Recent Embolic Event: A Transesophageal Echocardiographic Study,” J. Am. Coll. Cardiol. 25:452-459, Abstract Only.
Stokes, K. (Jun. 1990). “Implantable Pacing Lead Technology,” IEEE Engineering in Medicine and Biology pp. 43-49.
Su, P. et al. (Sep. 2008, e-pub. May 8, 2007). “Occluding the Left Atrial Appendage: Anatomical Considerations,” Heart 94(9):1166-1170.
Subramanian, V.A. et al. (Dec. 1997). “Minimally Invasive Direct Coronary Artery Bypass Grafting: two-Year Clinical Experience,” Ann. Thorac. Surg. 64(6):1648-1653, Abstract Only.
Subramanian, V.A. (Jun. 1997). “Less Invasive Arterial CABG on a Beating Heart,” Ann. Thorac. Surg. 63(6 Suppl.):S68-S71.
Suehiro, S. et al. (1995). “Echocardiography-Guided Pericardiocentesis With a Needle Attached to a Probe,” Ann. Thoracic Surg. 61:741-742.
Sun, F. et al. (Feb. 2006). “Subxiphoid Access to Normal Pericardium with Micropuncture Set: Technical Feasibility Study in Pigs,” Radiology 238(2):719-724.
Supplementary Search Report dated Mar. 14, 2011, for EP Application No. 04 794 730.4, filed on Oct. 11, 2004, 4 pages.—(1.41).
Szili-Torok, T. et al. (2001). “Transseptal Left heart Catheterisation Guided by Intracardiac Echocardiography,” Heart 86:e11-e15.
Tabata, T. et al. (Feb. 1, 1998). “Role of Left Atrial Appendage in left Atrial Reservoir Function as Evaluated by Left Atrial Appendage Clamping During Cardiac Surgery,” The American Journal of Cardiology 81:327-332.
Tomar, M. et al. (Jul.-Aug. 2006). “Transcatheter Closure of Fossa Ovalis Atrial Septal Defect: A Single Institutional Experience,” Indian Heart Journal 58(4):325-329.
Troughton, R.W. et al. (Feb. 28, 2004). “Pericarditis,” The Lancet 363:717-727.
Ulicny K.S. et al. (Jun. 1992). “Conjoined Subrectus Pocket for Permanent Pacemaker Placement in the Neonate,” Ann Thorac Surg. 53(6):1130-1131, Abstract Only.
Valderrabano, M. et al. (Sep. 2004). “Percutaneous Epicardial Mapping During Ablation of Difficult Accessory Pathways as an Alternative to Cardiac Surgery,” Heart Rhythm 1(3):311-316.
Von Korn, H. et al. (2006). “Simultaneous Combined Interventional Percutaneous Left Atrial Auricle and Atrial Septal Defect Closure,” Heart 92:1462.
Wang, T.J. et al. (Aug. 27, 2003). “A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community,” American Medical Association 290(8):1049-1056.
Watkins, L. et al. (Nov. 1982). “Implantation of the Automatic Defibrillator: The Subxiphoid Approach,” Ann. of Thoracic Surg. 34(5):515-520.
W.L. Gore & Associates (Aug. 11, 2006). “Gore HelexTM Septal Occluder,” located at http://www.fda.gov/cdrh/pdf5/p050006a.pdf, last visited on Jun. 14, 2007, 3 pages.
Wolber, T. et al. (Jan. 2007). “Potential Interference of Small Neodymium Magnets with Cardiac pacemakers and Implantable Cardioverter-defibrillators,” Heart Rhythm 4(1):1-4.
Wolf, P.A. et al. (Aug. 1991). “Atrial Fibrillation as an Independent Risk Factor For Stroke: The Framingham Study,” Stroke 22(8):983-988.
Wolf, P.A. et al. (Feb. 9, 1998). “Impact of Atrial Fibrillation on Mortality, Stroke, and Medical Costs,” Arch Intern Med 158:229-234.
Wolf, P.A. et al. (Oct. 1978). “Epidemiologic Assessment of Chronic Atrial Fibrillation and Risk of Stroke: The Fiamingham Study,” Neurology 28:973-977.
Wong, J.W.W. et al. (2006). “Impact of Maze and Concomitant Mitral Valve Surgery on Clinical Outcomes,” The Annals of Thoracic Surgery 82:1938-1947.
Wongcharoen, W. et al. (Sep. 2006). “Morphologic Characteristics of the Left Atrial Appendage, Roof, and Septum: Implications for the Ablation of Atrial Fibrillation,” Journal of Cardiovascular Electrophysiology 17(9):951-956.
Wood, M.A. (Jan. 2006). “Percutaneous Pericardial Instrumentation in the Electrophysiology Laboratory: A Case of Need,” Heart Rhythm 3(1):11-12.
Written Opinion from the International Searching Authority dated Sep. 14, 2012, for PCT Patent Application No. PCT/US2012/41285, filed on Jun. 7, 2012; 6 pages (9.40).
Written Opinion dated May 19, 2008, for PCT Application No. PCT/US06/013459, filed on Apr. 7, 2006, 6 pages. (2.40).
Written Opinion of the International Search Report dated Dec. 4, 2017, for PCT Application No. PCT/US2017/053069, filed on Sep. 22, 2017, 4 pages.
Written Opinion of the International Searching Authority dated Aug. 8, 2014, for PCT Application No. PCT/US2014/020030, filed on Mar. 3, 2014, 6 pages.
Written Opinion of the International Searching Authority dated Feb. 27, 2009, for PCT Application No. PCT/US2008/003938, filed on Mar. 25, 2008, 10 pages.
Written Opinion of the International Searching Authority dated Jul. 30, 2010, for PCT Application No. PCT/US2008/076703, filed on Sep. 17, 2008, 8 pages.
Written Opinion of the International Searching Authority dated Jun. 1, 2010, for PCT Application No. PCT/US2010/029668, filed on Apr. 1, 2010, 8 pages.
Written Opinion of the International Searching Authority dated Jun. 24, 2016, for PCT Application No. PCT/US2016/024117, filed on Mar. 24, 2016, 4 pages.
Written Opinion of the International Searching Authority dated May 4, 2017, for PCT Application No. PCT/US2017/019495, filed on Feb. 24, 2017, 7 pages.
Wudel, J.H. et al. (Apr. 3, 2008). “Video-Assisted Epicardial Ablation and left Atrial Appendage Exclusion for Atrial Fibrillation: Extended Follow-Up,” The Annals of Thoracic Surgery 85:34-38.
Wyse, D.G. et al. (Dec. 5, 2002). “Of ‘Left Atrial Appendage Amputation, Ligation, or Occlusion In Patients with Atrial Fibrillation’,” N Engl J Med 347(23):1825-1833, Abstract Only.
Yamada, Y. et al. (Aug. 2006). “Video-Assisted Thoracoscopy to Treat Atrial Tachycardia Arising from Left Atrial Appendage,” Journal of Cardiovascular Electrophysiology 17(8):895-898.
Zapolanski, A. et al. (May 2008). “Safe and Complete Exclusion of the left Atrial Appendage, A Simple Epicardial Approach,” Innovations 3(3):161-163.
Zenati, M.A. et al. (2004). “Mechanical Function of the Left Atrial Appendage Following Epicardial Bipolar Radiofrequency Ablation,” Cardiothoracic Techniques and Technologies X, Abstract 121A, p. 176.
Zenati, M.A. et al. (2005). “Modification of the Left Atrial Appendage,” Chapter 12 in Innovative Management of Atrial Fibrillation, Schwartzman, David ed., Blackwell Science Ltd., 5 pages.
Zenati, M.A. et al. (Sep. 2003). “Left Heart Pacing Lead Implantation Using Subxiphoid Videopericardioscopy,” Journal of Cardiovascular Electrophysiology 14(9):949-953.
Related Publications (1)
Number Date Country
20210236132 A1 Aug 2021 US
Provisional Applications (1)
Number Date Country
60921002 Mar 2007 US
Continuations (4)
Number Date Country
Parent 15634982 Jun 2017 US
Child 17236963 US
Parent 14625540 Feb 2015 US
Child 15634982 US
Parent 12363381 Jan 2009 US
Child 14625540 US
Parent 12055213 Mar 2008 US
Child 12363381 US